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Regulation of cerebral cortical
neurogenesis by the Pax6
transcription factor
Martine N. Manuel†, Da Mi†, John O. Mason and David J. Price*
Centre for Integrative Physiology, The University of Edinburgh, Edinburgh, UK
Understanding brain development remains a major challenge at the heart of
understanding what makes us human. The neocortex, in evolutionary terms the newest
part of the cerebral cortex, is the seat of higher cognitive functions. Its normal
development requires the production, positioning, and appropriate interconnection of
very large numbers of both excitatory and inhibitory neurons. Pax6 is one of a relatively
small group of transcription factors that exert high-level control of cortical development,
and whose mutation or deletion from developing embryos causes major brain defects
and a wide range of neurodevelopmental disorders. Pax6 is very highly conserved
between primate and non-primate species, is expressed in a gradient throughout the
developing cortex and is essential for normal corticogenesis. Our understanding of
Pax6’s functions and the cellular processes that it regulates during mammalian cortical
development has significantly advanced in the last decade, owing to the combined
application of genetic and biochemical analyses. Here, we review the functional
importance of Pax6 in regulating cortical progenitor proliferation, neurogenesis, and
formation of cortical layers and highlight important differences between rodents and
primates. We also review the pathological effects of PAX6 mutations in human
neurodevelopmental disorders. We discuss some aspects of Pax6’s molecular actions
including its own complex transcriptional regulation, the distinct molecular functions of
its splice variants and some of Pax6’s known direct targets which mediate its actions
during cortical development.
Keywords: proliferation, cell cycle, differentiation, neuronal fate, neurotransmitter fate, cortical lamination, BAF
complex, Meis2
Introduction
The expansion of the cerebral cortex is a major hallmark of mammalian evolution, particularly in
the primate lineages where it achieves its greatest complexity in humans (Martin, 1990). Despite
great variation in size, there are many similarities in the structure and function of the cerebral
cortex across all mammalian species. These similarities have encouraged neuroscientists to use
relatively simple cortices, such as those of rodents, as models in which to investigate biological
processes and mechanisms with likely relevance to humans. The strength of rodent models, in par-
ticular mice, derives in large part from the genetic and transgenic approaches that can be used to
study molecular mechanisms. Much of the research described in this review comes from studies of
mice and the view of cortical development and Pax6’s role in that process presented here is strongly
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biased toward mouse corticogenesis. It is important to recognize,
however, that signiﬁcant diﬀerences exist between the develop-
ing and mature cortices of primate and non-primate species that
are more than just diﬀerences of scale, and we shall highlight
some of these. It is remarkable that many high-level regulatory
genes such as Pax6 are themselves extremely highly conserved
between primates and non-primates although they inﬂuence and
control aspects of cortical development that diﬀer: for exam-
ple, the amino acid sequences of human PAX6 and mouse Pax6
are identical (Ton et al., 1992) although Pax6’s expression in pri-
mate embryos extends to cortical structures that do not exist in
mice. This implies that evolutionary changes in the functions of
these regulators have been achieved by changes in the mecha-
nisms regulating their expression and in the ways in which the
downstream molecular networks respond to them, but we know
almost nothing about these evolutionary changes at a molecular
level.
The cerebral cortex is derived from the dorsal com-
ponent (or pallium) of the embryonic telencephalon,
which is itself the anterior-most subdivision of the fore-
brain (Kiecker and Lumsden, 2005). The cerebral cortex can be
further sub-divided into distinct regions, including the neocor-
tex, a novel acquisition of mammals that has evolved between
the phylogenetically older archicortex (comprising entorhinal
cortex, retrosplenial cortex, subiculum, and hippocampus)
and paleocortex (olfactory piriform cortex). The evolutionary
expansion of the neocortex is thought to account for much of the
increase in overall brain size and complexity in more advanced
species (Krubitzer and Kaas, 2005; O’Leary et al., 2007). The
neocortex (hereafter referred to simply as cortex) contains an
extraordinarily large number of neurons arrayed in a six-layered
sheet, with neurons in each layer organized into a complex net-
work of local circuits and subcortical connections. In primates,
some of these layers are subdivided in some cortical areas: for
example, in primary visual cortex, layer 4 is subdivided into
layers 4a, b, and c. The primate cortex is also characterized by an
expansion of the superﬁcial layers of the cortex, layers 2 and 3
(also known as the supragranular layers), which have an impor-
tant function in the transfer of information between cortical
areas. Increased intracortical information processing is likely to
have contributed to heightened cognitive ability. In all mammals,
the cortex comprises two major groups of neurons: the majority
are excitatory glutamatergic projection neurons (70–80%), which
exhibit a characteristic pyramidal morphology and extend axons
to distant intracortical, subcortical, and subcerebral targets; a
minority are inhibitory GABAergic non-pyramidal interneurons
(25–30% in primates, 15–20% in rodents), which have short
axons and project locally (Hendry et al., 1987; Beaulieu, 1993).
An appropriate balance between the excitatory and inhibitory
circuitry of the cortex is critical for its normal function.
Pax6 is a pivotal gene in CNS development. It is expressed
when the major components of the developing CNS ﬁrst emerge
after neural tube closure and its expression patterns change con-
siderably as major structures such as the cerebral cortex specialize
and expand. Its expression plays a major role in the subsequent
development of the regions that continue to express it. In this
review we shall discuss how Pax6 plays critical roles in aspects
of corticogenesis that include the early patterning of telencephalic
subdivisions, control of cortical cell number, normal cortical layer
formation and the development of the correct balance of exci-
tatory and inhibitory neurons. We shall review what is known
about the upstream control of Pax6’s transcription, the molecular
basis of its functions and its actions on genes downstream of it
and the cellular processes they regulate.
Corticogenesis in Rodents and
Primates and the Cortical Expression
of Pax6
The closure of the neural tube is accompanied by its dispro-
portionate expansion anteriorly to generate the early forebrain.
The earliest cortical progenitors undergo symmetric prolifera-
tive divisions at the ventricular surface to amplify a pool of
progenitors, an increasing proportion of which then divide asym-
metrically to regenerate progenitors and to produce other cell
types including neurons.
In mouse, the generation of excitatory cortical neurons occurs
between embryonic day 11 (E11) and E18 (Gillies and Price,
1993; Price et al., 1997; Levers et al., 2001). Their progenitors
are located in one of two pallial germinal epithelia, namely
the ventricular zone (VZ), which lies adjacent to the ventri-
cles, and the subventricular zone (SVZ), which lies just above
the VZ (Figure 1). The early symmetrically dividing cortical
neuroepithelial cells (NECs) that each produce two daughter
NECs per division and whose population rapidly expands lat-
erally and radially, transform into another type of progenitor
called, for historical reasons, radial glial cells (RGCs; Figure 1).
RGCs, whose long processes span the neuroepithelium, have
been known for a long time to provide guidance for migrat-
ing neurons (Levitt and Rakic, 1980; Rakic, 1988; Hatten, 2002;
Tan and Shi, 2013). Despite having morphological and molecular
features associated with glial cells, they are progenitors capable
of generating other types of progenitor, neurons and glial cells
(Malatesta et al., 2000, 2003; Miyata et al., 2001; Noctor et al.,
2001; Skogh et al., 2001; Heins et al., 2002; Tan and Shi, 2013).
RGCs constitute the majority of the VZ progenitor population.
They are often referred to as apical progenitors (APs) due to
the location of their cell body close to the ventricular or apical
surface of the VZ, to which they extend a short process while
sending a longer basal process radially to the pial surface of the
cortex (Cameron and Rakic, 1991; Bentivoglio and Mazzarello,
1999; Tan and Shi, 2013). As they progress through the cell
cycle, RGCs undergo interkinetic nuclear migration. Their
nucleus migrates radially through the cytoplasm such that mito-
sis occurs at the apical ventricular surface and S-phase at a
basal position in the VZ. While at early stages of corticoge-
nesis RGCs predominantly self-renew via symmetric divisions,
they progressively switch to asymmetric divisions, which pro-
duce one daughter RGC and one daughter cell with a heightened
level of commitment (Noctor et al., 2001, 2004; Haydar et al.,
2003; Huttner and Kosodo, 2005; Tan and Shi, 2013). The dif-
ferentiating daughter cell either migrates radially to the pial
surface and diﬀerentiates into a neuron or migrates to the
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FIGURE 1 | Cortical germinal areas of rodents and primates. Coronal
section through the developing cortex of a rodent and a primate showing
progenitor types and whether they express Pax6 and/or Tbr2. CP, cortical
plate; SP, subplate; IZ, intermediate zone; SVZ, subventricular zone; ISVZ,
inner subventricular zone; OSVZ, outer subventricular zone; VZ, ventricular
zone; aRG, apical radial glia; bRG, basal radial glia; aIPC, apical
intermediate progenitor cell; bIPC, basal intermediate progenitor
cell.
SVZ to become an intermediate progenitor cell (IPC), also
called a basal progenitor (BP) or basal IPC (bIPC; Figure 1;
Haubensak et al., 2004; Miyata et al., 2004; Noctor et al., 2004).
BPs accumulate in the SVZ and divide mainly symmetrically
to generate two neurons. It is thought that most cortical
projection neurons are generated by BPs (Farkas and Huttner,
2008). In addition to RGCs, the VZ contains another smaller
subpopulation of APs called short neural precursors (SNPs),
also known as apical IPCs (aIPC; Figure 1). Unlike RGCs,
aIPCs do not self-renew and only generate pairs of neu-
rons via symmetric divisions (Gal et al., 2006; Tan and Shi,
2013).
Signiﬁcant progress in understanding the mechanisms under-
lying corticogenesis has been made through analysis of gene
expression in both progenitor cells and post-mitotic neurons.
Such studies have revealed a crucial role for transcription fac-
tors (TFs) as molecular markers of distinct progenitor and
neuron types and as key regulators of progenitor cell prolifer-
ation and cell fate decisions. At the onset of neurogenesis, TFs
including Pax6, Emx2, and Tlx expressed in the cortical neu-
roepithelium function mainly to inﬂuence areal patterning and
regulate progenitor cell proliferation (Bishop et al., 2000, 2002;
Muzio et al., 2002; Muzio and Mallamaci, 2003; Stenman et al.,
2003a,b; Hevner, 2006). As neurogenesis proceeds, a large num-
ber of TFs are involved in regulating the balance between pro-
genitor cell proliferation and neuronal diﬀerentiation. Regulating
this balance is essential for the generation of the correct pro-
portions of diﬀerent classes of neurons and subsequent circuit
assembly.
During the neurogenic period in the mouse cortex, Pax6 is
expressed by VZ APs in a high rostro-lateral to low caudo-medial
gradient (Figures 2 and 3). As well as being graded spatially,
the expression of Pax6 is also graded temporally, with high-
est levels present at the onset of corticogenesis. APs that give
rise to BPs transiently express the proneural TF Neurogenin 2
(Ngn2; Britz et al., 2006). Pax6 is not expressed in BPs which are
characterized by their expression of another TF, Tbr2, or in post-
mitotic neurons which express Tbr1 (Figure 1; Englund et al.,
2005). Thus a sequential Pax6 → Ngn2 → Tbr2 → Tbr1 expres-
sion correlates with the transition of APs to BPs to post-mitotic
neurons.
In the macaque cortex, Rakic (1974) showed that cortical neu-
rogenesis occurs between E45 and E100. Gestation in this species
lasts 165 days and so cortical neurons are generated relatively
earlier in gestation in primates than in rodents. The primate
SVZ forms earlier and shows a much greater expansion than
in rodents, becoming the predominant progenitor zone by mid-
corticogenesis (Smart et al., 2002). It is split into the inner and
outer SVZs separated by an inner ﬁber layer (Smart et al., 2002;
Lukaszewicz et al., 2005; Zecevic et al., 2005; Fietz et al., 2010;
Hansen et al., 2010; Florio and Huttner, 2014). The inner subven-
tricular zone (ISVZ) contains mainly IPCs similar to those in the
rodent SVZ whereas the outer subventricular zone (OSVZ) con-
tains mainly basal RGCs (bRGCs) similar to the APs present in
the rodent VZ (Figure 1). bRGCs undergo proliferative divisions
and self renewing asymmetric divisions to generate one bRGC
daughter cell and one IPC that can proliferate further (Fietz et al.,
2010; Hansen et al., 2010; Florio and Huttner, 2014). bRGCs have
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FIGURE 2 | The gradient expression pattern of Pax6 protein in the
mouse developing cortex. (A) A schematic diagram shows the Pax6 protein
(red) is normally expressed in a highrostrolateral to lowcaudomedial gradient in
the developing cortex during early cortical development. (B,C)
immunofluorescence staining for Pax6 protein in sagittal section (B) and coronal
section (C) from E12.5 mouse WT embryos (scale bars, 100 μm).
also been observed in the rodent SVZ but, while they consti-
tute about half of all progenitors present in the primate SVZ,
they account for only a minute fraction of the SVZ progenitors
in rodents (Figure 1). The OSVZ is the major source of supra-
granular layer neurons (Letinic et al., 2002; Lukaszewicz et al.,
2005).
The sequential Pax6 → Ngn2 → Tbr2 → Tbr1 expression
that correlates with the AP → BP → post-mitotic neuron tran-
sition in mice is not found during primate corticogenesis. In
contrast to rodents, Pax6 is expressed by progenitors in the
VZ, ISVZ, and OSVZ in primates (Figure 3; Fietz et al., 2010;
Betizeau et al., 2013; Florio and Huttner, 2014) and many pro-
genitors co-express Pax6 and Tbr2 (Figure 1). In the macaque,
the majority of VZ progenitors (60–80%) express only Pax6 dur-
ing early and mid-stages of corticogenesis (up to E79), but at later
stages (after E79) 40% of them co-express Tbr2 (Betizeau et al.,
2013; Florio and Huttner, 2014; Figure 1). In the ISVZ, 60–80%
of progenitors co-express Pax6 and Tbr2, 5–30% express only
Tbr2 and less than 15% express only Pax6. In the OSVZ, Pax6,
and Tbr2 are co-expressed by 25–50% of progenitors while
20–35% express only Pax6 and 10–20% only Tbr2 (Figure 1;
Betizeau et al., 2013; Florio and Huttner, 2014).
In mice, cortical GABAergic interneurons originate from dis-
tant germinal domains in the ganglionic eminences and fol-
low tangential migratory routes to reach the developing cortex
(Gelman and Marin, 2010). In primates, the origin of cortical
interneurons is controversial. It has been proposed that while
many interneurons have a ventral telencephalic origin, a signif-
icant fraction are produced in the progenitor layers of the cor-
tex itself during the second half of corticogenesis (Letinic et al.,
2002; Zecevic et al., 2005; Petanjek et al., 2008; Jakovcevski et al.,
2011). However, a recent study by Hansen et al. (2013) found no
evidence of interneuron production in the cortical wall. Instead,
their analysis suggests that, as in rodents, the vast majority of
human cortical interneurons are produced in the ganglionic
eminences (Hansen et al., 2013).
In all mammalian species, the positions adopted by neurons
migrating from the cortical progenitor zones to the overlying
developing cortical plate (CP) are related to their birthdate. Each
successive generation of newly born projection neurons bypasses
earlier-born neurons and settles close to the pial edge of the CP.
Thus, cortical layers (with the exception of layer 1) are formed
in a deep-ﬁrst superﬁcial-last sequence (Angevine and Sidman,
1961; Berry and Rogers, 1965; Rakic, 1974; McConnell, 1995;
Tan and Shi, 2013). When projection neurons arrive in their ﬁnal
laminar positions, they undergo terminal diﬀerentiation includ-
ing elaboration of their dendrites and axons to establish con-
nections and eventually form the cortical circuitry. Projection
neurons in each layer tend to exhibit similar gene expression
patterns, morphologies and organization of aﬀerent and eﬀerent
connections (Stiles and Jernigan, 2010).
Human Brain Disorders Associated
with PAX6 Mutations
In humans, heterozygous loss-of-function mutations of PAX6
cause sight-threatening congenital eye defects, typically includ-
ing severe hypoplasia of the iris (aniridia) and retina. These
mutations are also associated with a range of neurological
and psychiatric conditions including nystagmus, impaired audi-
tory processing and verbal working memory, autism, and
mental retardation (Malandrini et al., 2001; Bamiou et al., 2004,
2007a,b; Davis et al., 2008; Hingorani et al., 2009; Maekawa et al.,
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FIGURE 3 | Comparison of Pax6 expression in embryonic human and
mouse cortex. Images from human cortices at 8, 10, and 12 post-coital
weeks (PCWs) were generated using material from the Human Developmental
Biology Resource (www.hdbr.org) as part of the HuDSeN (Kerwin et al., 2010)
human gene expression spatial database (http://www.hudsen.org) based at
Newcastle University. PAX6 is expressed in the ventricular zone (VZ) and
subventricular zone (SVZ) at 8 PCW. The SVZ divides into an outer and an
inner subventricular zone (OSVZ and ISVZ), both of which continue to express
PAX6. In mice, Pax6 expression is confined almost exclusively to the VZ
during corticogenesis, as shown here at embryonic days (E) 13.5, 15.5, and
17.5. Additional abbreviations: CP, cortical plate; IZ, intermediate zone.
2009). These conditions are linked to structural brain defects
including reduced size of the corpus callosum and anterior
commissure, abnormalities of the cerebral cortex and cere-
bellum and absence of the pineal gland (Sisodiya et al., 2001;
Free et al., 2003; Mitchell et al., 2003; Bamiou et al., 2004, 2007b;
Ellison-Wright et al., 2004).
Only four cases of children with mutations in both PAX6 alle-
les (compound heterozygotes) have been reported (Glaser et al.,
1994; Schmidt-Sidor et al., 2009; Solomon et al., 2009). Two of
them survived past birth, one only for about 1 week (Glaser et al.,
1994), the other until at least 4 years (Solomon et al., 2009).
The former had anophthalmia, the latter microphthalmia, and
both had numerous defects in the CNS including agenesis
of the corpus callosum and microcephaly. Glaser et al. (1994)
described a disturbed stratiﬁcation of the cerebral cortex with
heterotopic islands of germinal and ependymal cells, as well
as focal polymicrogyria of the cerebral cortex. Two other cases
were sibling fetuses with the pregnancies terminated at 21 and
23 weeks (Schmidt-Sidor et al., 2009). In both cases the brain was
very small, ﬁlling only 1/3 of the cranial cavity, and displayed
completely disorganized structures of the brain hemispheres
and cerebellum. Microscopic analysis showed that the cerebral
hemispheres contained an enormous amount of germinal matrix
both in the inner parts and at the surface of the hemispheres.
The cortex was very narrow with a paucity of cells with an irreg-
ular distribution of large neurons. The structure of the cortex
was disturbed with a thick layer of germinal cells on its surface,
a poorly deﬁned marginal zone and no normal stratiﬁcation. In
the entire cortex the cells were mainly in clusters. The devel-
opment of the white matter was also severely disturbed. The
intermediate zone was absent. In several places of the cortex and
also between clusters of neuroblasts inside the brain hemispheres
there were fascicles of axons which did not form normal tracts.
The heterotopia of germinal cells observed in the human com-
pound heterozygotes (Figure 4A) are reminiscent of the clusters
of germinal cells found in the intermediate zone of the cortex of
Pax6−/− mouse embryos (Figure 4B; Caric et al., 1997). In these
Pax6mutant embryos it is thought that the clusters form as a con-
sequence of a cell non-autonomous migration defect (Caric et al.,
1997).
Structure and Transcriptional
Regulation of the Pax6 Locus
In both human and mouse, the Pax6 gene has 16 exons dis-
tributed over a 30 kb genomic region including alternatively
spliced exons alpha and 5a (Glaser et al., 1992; Williams et al.,
1998; Kammandel et al., 1999; Plaza et al., 1999a; Xu et al.,
1999b). Four transcription start sites have been identiﬁed in
mouse Pax6, associated with the P0, P1, Palpha, and P4 promoters
respectively (Figure 5; Kammandel et al., 1999; Xu et al., 1999b;
Kleinjan et al., 2004; Morgan, 2004). Transcriptional regulation
of the Pax6 locus is particularly complex. A number of short-
range regulatory elements have been identiﬁed in the vicinity
of the Pax6 coding region which control tissue-speciﬁc Pax6
expression (Figure 5; Kammandel et al., 1999; Plaza et al., 1999b;
FIGURE 4 | Histology of Pax6−/− developing cortex in human and
mouse. (A) Coronal section through the cortex of a fetus with a compound
heterozygosity for two PAX6 mutations showing a layer of germinal cells on
the surface of the cortex (arrow) and heterotopia of germinal cells within the
cortex (arrowhead). Photograph taken from Schmidt-Sidor et al. (2009). (B)
Coronal section through the cortex of a Pax6−/− mutant mouse embryo
showing clusters of germinal cells in the intermediate zone (arrowhead).
Photograph from Caric et al. (1997).
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FIGURE 5 | Structure and transcriptional regulation of the PAX6 locus.
Schematic map of human chromosome 11p13 shows the locations of the
PAX6 and ELP4 loci, which are in an antisense orientation relative to each
other. The locations of PAX6 promoters (P0, P1, Pa, and P4) are indicated by
black arrows. Blue rectangles indicate PAX6 exons, while black rectangles
below the line indicate ELP4 exons. The known highly conserved regulatory
elements, such as E60, E100 and RB, are indicated by purple ellipses. The
breakpoints of the two distal-most aniridia-associated rearrangements are
indicated by “SGL” and “SIMO.” The location of the downstream regulatory
region (DRR) is shown by red arrows. The known DNaseI hypersensitive sites
(HS sites) within the DRR region are shown by red arrows. The schematic
maps of YACs Y593 (420 kb) and Y589 (310 kb) are indicated. In transgenic
mice, Y593, but not Y589, rescues the mouse Sey phenotype and
homozygous Sey lethality.
Kleinjan et al., 2001, 2004; Griﬃn et al., 2002). Some of these
elements exhibit overlapping tissue speciﬁcity, particularly in the
eye, telencephalon and diencephalon, suggesting that they exert
functions through cooperative interactions.
Although these short-range regulatory elements account for
much of Pax6’s normal expression pattern in mice, genetic
analyses in both humans and mice revealed that they are
insuﬃcient to drive the full pattern of Pax6 expression, par-
ticularly in the eye and forebrain (Kim and Lauderdale, 2006;
Kleinjan et al., 2006; McBride et al., 2011). The ﬁrst evidence
that PAX6 expression is inﬂuenced by distant regulatory ele-
ments located far downstream of PAX6’s coding exons came
from studies of aniridia patients, a subset of which harbor
chromosomal rearrangements whose breakpoints are located far
downstream of the PAX6 transcriptional unit (Fukushima et al.,
1993; Fantes et al., 1995; Lauderdale et al., 2000; Kleinjan et al.,
2001; Crolla and Van Heyningen, 2002). The most distant of
these breakpoints, designated “SIMO,” is located 124 kb down-
stream of the PAX6 polyadenylation site (Fantes et al., 1995;
Kleinjan et al., 2001; Figure 5). The functional importance of
regulatory regions around distant breakpoints was conﬁrmed
by the ﬁnding that a yeast artiﬁcial chromosome (YAC) com-
prising 420 kb of the human PAX6 coding sequence and ﬂank-
ing regions stretching beyond the SIMO breakpoint rescues
the mouse small eye (Sey) phenotype, whereas a YAC trans-
gene with 110 kb less DNA sequence at the 3′ end fails to
rescue (Kleinjan et al., 2001). Subsequent analyses revealed the
presence of essential 3′ distant regulatory elements within a
75 kb region termed the PAX6 downstream regulatory region
(DRR) located 3′ of the SIMO breakpoint (Figure 5; Schedl et al.,
1996; Kleinjan et al., 2001; McBride et al., 2011). A number
of other conserved regulatory elements, including E60, E100,
and RB (Figure 5), located either upstream or downstream
of the DRR region are thought to be crucial for the induc-
tion of PAX6 expression in the eye and forebrain (Griﬃn et al.,
2002; Kleinjan et al., 2002, 2006; Kim and Lauderdale, 2006;
McBride et al., 2011).
We recently reported a detailed examination of a series of
novel transgenic reporter mice lines, carrying versions of either
the full length 420 kb YAC described above or truncated versions
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that lacked putative regulatory elements. The YAC transgenes
were modiﬁed by the introduction of a tau-GFP reporter cas-
sette into the ﬁrst coding exon of PAX6, such that GFP expression
marks cells in which the transgenes are expressed. We found that
regulatory elements that lie outside the 420 kb YAC transgene are
required for correct PAX6 expression in sub-regions of the telen-
cephalon and diencephalon, indicating that recapitulation of the
full PAX6 expression pattern requires even more elements than
had previously been thought (Mi et al., 2013b).
The Pax6 locus is subject to autoregulation – Pax6 has been
shown to regulate its own expression. Putative Pax6 binding
sites have been identiﬁed in Pax6 regulatory elements in sev-
eral species. For example, in Drosophila, two intronic enhancer
elements containing putative Pax6 binding sites mediate auto-
activation of eyeless (a Drosophila Pax6 homolog) in the ner-
vous system and eye (Hauck et al., 1999). These elements may
serve the same function in vertebrates as they exhibit sig-
niﬁcant sequence identity between Drosophila and vertebrate
species (Chow et al., 1999). In addition, Pax6 directly interacts
with putative Pax6-responsive elements within the head sur-
face ectoderm-speciﬁc enhancer of mouse Pax6, positively reg-
ulating its own transcription (Aota et al., 2003). Similarly, Pax6
autoregulation in the forebrain was revealed through the iden-
tiﬁcation of a highly conserved regulatory element (CE2) in
intron 7 of mouse Pax6 (Figure 5). Overexpressing either Pax6
or its alternative spliced isoform Pax6(5a) positively autoreg-
ulated expression of the endogenous Pax6 locus in Neuro2D
and NIH3T3 cell lines (Pinson et al., 2006). The Pax6 locus is
also subject to negative autoregulation, whereby Pax6 represses
transcription of the Pax6 locus, as shown in the developing
telencephalon (Manuel et al., 2007). In summary, these studies
highlight the fact that appropriate levels of Pax6 expression are
regulated by both positive and negative autoregulation during
development.
Pax6 Regulates Cell Cycle Length and
Cell Cycle Exit
Generating the correct number of cortical neurons of the correct
types involves changes in both the mode of division of cortical
progenitors and length of their cell cycle. As discussed above, cor-
tical progenitors switch progressively from proliferative symmet-
rical divisions to diﬀerentiative asymmetrical divisions during
corticogenesis. At the same time, the length of the cell cycle in AP
cells in mouse cortex increases from 8 h at the onset of neuroge-
nesis (E10) to 18 h at the end (E18), largely due to lengthening of
the G1 phase (Takahashi et al., 1993, 1995; Estivill-Torrus et al.,
2002). Subsequent studies showed that G1 lengthening acts to
promote the genesis of BP cells which have much longer cell cycle
length (around 26 h in E14.5 mouse cortex) due to increase in the
G1 length (Arai et al., 2011). In the macaque, AP cell cycle length
is much longer than in rodents and it follows a diﬀerent devel-
opmental course (Kornack and Rakic, 1998). It lengthens linearly
from 23 h at E40 to 54 h at E60, then shortens linearly to 27 h
by E80 (Kornack and Rakic, 1998). As the neurogenic period is
10 times longer than in rodents, macaque cortical progenitors
undergo manymore rounds of division even though the duration
of the cell cycle is longer (Kornack and Rakic, 1998), generating a
greater number of cortical cells and a larger cortex.
There ismounting evidence that TFs exert region-speciﬁc con-
trol of cortical progenitor cell cycle progression. Pax6 is one
of a number of TFs that are expressed in distinct gradients
across cortical areas (Zaki et al., 2003; Sansom and Livesey, 2009;
Salomoni and Calegari, 2010; Georgala et al., 2011a) and several
studies have implicated Pax6 in the temporal and spatial control
of cell cycle duration in cortical progenitors. Loss of Pax6 during
early cortical development (E12.5) in mice in vivo led to a short-
ening of the cell cycle of progenitors coupled with higher propor-
tions of asymmetrical divisions, resulting in a temporary increase
in the production of post-mitotic neurons (Warren et al., 1999;
Estivill-Torrus et al., 2002; Walcher et al., 2013). Experiments
with cultured Pax6−/− mutant cortical cells showed that they too
exhibit accelerated proliferation, indicating that Pax6’s eﬀects on
the cell cycle are cell autonomous (Estivill-Torrus et al., 2002). In
contrast, at the mid-corticogenesis stage (E15.5) Pax6−/− pro-
genitor cells proliferated more slowly than wild type controls,
showing that the eﬀects of Pax6 on the cell cycle of cortical
progenitors are context-dependent.
Gain of function studies also support the idea that Pax6 con-
trols cell cycle progression. For example, forced expression of
Pax6 impairs progenitor cell proliferation in vitro (Heins et al.,
2002; Hack et al., 2004; Cartier et al., 2006). In PAX77 mice,
which express PAX6 protein in its normal pattern but at approx-
imately double the wild type level, there is a reduction in the
number of proliferating progenitors in the rostral and central
cortex, the areas where levels of Pax6 expression are normally
highest (Manuel et al., 2007). Further, APs located in rostral cor-
tical areas proliferate more slowly in these mice (Georgala et al.,
2011a,b). Thus, both gain and loss of Pax6 function studies
have revealed powerful context-speciﬁc eﬀects of Pax6 on the
cell cycle of progenitor cells in a variety of cortical areas and
stages.
Early in corticogenesis, expression levels of Pax6 vary between
diﬀerent cortical regions but its expression levels become
increasingly uniform with embryonic age (Mansouri et al., 1994;
Stoykova and Gruss, 1994; Manuel et al., 2007). Some of the evi-
dence cited above indicates that the actions of Pax6 on the
cell cycle of cortical progenitors are associated with its expres-
sion levels. This assumption is strongly supported by our recent
study in which cell cycle parameters were systematically exam-
ined in diﬀerent cortical regions at diﬀerent developmental stages
using mouse models with either constitutive or conditional loss
of Pax6 function (Mi et al., 2013a). During early corticogene-
sis (E12.5), when the Pax6 gradient is steepest, areas of highest
expression correlate with regions where the cell cycle duration
is longest (Figure 6). Loss of Pax6 causes shortening of the cell
cycle only in these areas (Figure 6). In normal embryos at older
ages, the Pax6 gradient becomes progressively more uniform
across the cortex, as does cell cycle length, and loss of Pax6
causes shortening of the cell cycle in all areas (Figure 6; Mi et al.,
2013a). Taken together, these studies indicate that Pax6 primarily
exerts a repressive action on the cell cycle progression of cor-
tical progenitors, and distinct expression levels of Pax6 confer
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FIGURE 6 | Effect of loss of Pax6 on cortical progenitor cell cycle
parameters. Diagram showing the cell cycle length and S-phase length of
cortical progenitors at a rostral or caudal position in Wild type or Pax6−/−
embryos. At E12.5 Pax6 is normally expressed in a high rostral to low caudal
gradient and loss of Pax6 results in a shortening of the cell cycle rostrally with no
effect on S-phase length. At E14.5 Pax6 is expressed in a flatter rostro-caudal
gradient and loss of Pax6 causes a shortening of the cell cycle both rostrally
and caudally while the S-phase length remains unaffected.
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its region and age -speciﬁc role in regulating progenitor cell
proliferation.
As well as regulating the length of the cell cycle in cortical
progenitors, Pax6 is involved in the control of cell cycle exit. In
the Pax6sey/sey mutant cortex, the number of progenitor cells that
exit the cell cycle during early corticogenesis (E12.5) is increased,
leading to a smaller progenitor pool and an increased proportion
of newborn neurons (Estivill-Torrus et al., 2002; Quinn et al.,
2007). A similar eﬀect has been seen in the eye and the spinal
cord, where loss of Pax6 caused precocious neuronal diﬀer-
entiation due to premature cell cycle exit (Philips et al., 2005;
Bel-Vialar et al., 2007). Interestingly, a study using PAX77 mice
revealed that increasing Pax6 levels also causes an increase in
the proportion of progenitor cells exiting the cell cycle dur-
ing late corticogenesis (E15.5; Georgala et al., 2011b), indicating
that there is no simple dosage-dependent relationship between
Pax6 level and progenitor cell cycle exit rate. Recently, we found
that loss of Pax6 led to fewer progenitors exiting the cell cycle
at the PSPB (pallial–subpallial boundary) at E12.5, the area of
the telencephalon where Pax6 expression is highest, contrasting
with the previous ﬁnding that Pax6−/− cortical progenitors show
increased cell cycle exit at E12.5 (Estivill-Torrus et al., 2002). It
appears that, although a general function of Pax6 is to inﬂu-
ence cell cycle exit, the exact nature of its eﬀect depends on
the molecular and cellular context within which it acts. This
context may change corresponding to diverse Pax6 levels in dif-
ferent regions at diﬀerent developmental stages. In support of
this assumption, a number of independent analyses demonstrated
that Pax6 exerts diﬀerent control functions on progenitor prolif-
eration in diﬀerent cellular contexts: Pax6 enhances proliferation
in the neural retina of vertebrates (Marquardt et al., 2001) and
Drosophila (Dominguez et al., 2004), whereas it inhibits prolif-
eration of human glioblastoma cells (Zhou et al., 2005), cultured
corneal epithelial cells (Ouyang et al., 2006) and cortical progen-
itors in primary cell cultures (Heins et al., 2002; Haubst et al.,
2004) as well as in vivo (Estivill-Torrus et al., 2002; Berger et al.,
2007). Therefore, it is diﬃcult to conclude a simple univer-
sally consistent role of Pax6 in the regulation of cell cycle
exit.
Pax6 Direct Targets Regulating
Progenitor Cell Proliferation
As described above, Pax6 is important for the regulation
of cortical progenitor proliferation (Estivill-Torrus et al., 2002;
Manuel et al., 2007; Quinn et al., 2007; Georgala et al., 2011b;
Mi et al., 2013a,b). Cell cycle progression is driven by the con-
certed action of cyclin-dependent kinases (Cdks) and their acti-
vating partners, cyclins (Malumbres and Barbacid, 2005). Low
levels of Cdk activity are suﬃcient for cells to transit from G1
into S phase, whereas high-levels of Cdk activity are required
for the cell to undergo mitosis (Dehay and Kennedy, 2007;
Kaldis and Richardson, 2012). During G1, cells integrate and
respond to extracellular cues that either allow the cell to continue
cycling or promote its withdrawal from the cell cycle and begin
diﬀerentiation (Zetterberg et al., 1995). Progression through G1
is mainly driven by the activation of Cdk4/6 and their acti-
vating partners, D-type cyclins (Cyclin D1 and D2) as well as
Cdk2 and its partner Cyclin E (Malumbres and Barbacid, 2001,
2005). Cdk activity is negatively regulated by members of the
cyclin-dependent kinase inhibitors family (CKIs; Polyak et al.,
1994; Sherr and Roberts, 1995; Vidal and Koﬀ, 2000). The pri-
mary substrate of Cdks during G1 phase is the retinoblastoma
protein (pRb). pRb acts as a repressor of E2F TFs through
direct interaction. In quiescent cells, the activities of E2Fs are
repressed through direct interaction with hypophosphorylated
pRb. In cycling cells, mitogenic stimuli that elevate Cyclin lev-
els promote pRb phosphorylation by Cyclin/Cdk complexes,
which in turn prevents pRb from binding to E2Fs. Consequently,
pRb/E2F complexes are dissociated and free E2Fs are now
active and ready to drive the transcription of genes encod-
ing proteins that are involved in G1 phase progression and
DNA replication. Gene expression proﬁling studies showed that
Pax6 is capable of regulating the expression of a number of
cell cycle genes involved in G1 to S phase transition, such
as Cdk4, Cdk6, Ccnd1, Ccnd2, p27kip1, Cdc6, Mcm3, Mcm5,
Mcm6, Cdca2 and Cdca7, with many of them being repressed
by Pax6 (Sansom et al., 2009; Mi et al., 2013a,b). These ﬁnd-
ings are in line with the notion that Pax6 mainly acts as an
important regulator of progenitor cell proliferation during early
cortical development as reviewed above. Among the cell cycle
genes whose expression is regulated by Pax6, Pax6 direct tar-
gets identiﬁed to date include Cdk4, Cdk6, Mcm3, Cdca2, Cdca7,
and p27kip1 (Table 1; Duparc et al., 2007; Sansom et al., 2009;
Mi et al., 2013a,b).
It is interesting to note that in addition to its repressive
eﬀect, Pax6 can also activate expression of some cell cycle
genes (Holm et al., 2007; Osumi et al., 2008; Sansom et al., 2009;
Mi et al., 2013a,b; Xie et al., 2013). For example, Pax6 directly
promotes the expression of Cdk4 in neural stem cells in early
cortical development (Sansom et al., 2009). This supports the
concept that Pax6 has dual roles to both promote and inhibit
cell proliferation in the developing cortex, possibly through the
divergent functions of its DNA-binding subdomains (see below;
Walcher et al., 2013). Using transcriptome analysis of the cor-
tex in embryos with either gain and loss of Pax6 function,
Sansom et al. (2009) showed that Pax6 regulates a core transcrip-
tional network that controls cortical neural stem cell proliferation
in a dosage-dependent manner. They found that under normal
conditions in vivo, Pax6 has the potential to both promote and
inhibit stem cell proliferation by exhibiting opposing eﬀects on
the expression of diﬀerent sets of cell cycle genes, but when
Pax6 levels are increased, as in transgenic cortex overexpress-
ing Pax6, the neurogenic functions of Pax6 are dominant over
its ability to promote proliferation. This study is in line with
our ﬁnding that at the onset of corticogenesis, the repressive
eﬀect of Pax6 on progenitor cell proliferation and the Cdk/Cyclin
mediated phosphorylation of pRb is localized to regions of cor-
tex where Pax6 expression is normally highest, indicating a
relationship between the level of Pax6 expression and its anti-
proliferative eﬀect (Mi et al., 2013a). Given that Pax6 is expressed
in a gradient during early cortical development, the dosage-
dependent eﬀects of Pax6 on cell proliferation are important in
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the context of understanding how the cerebral cortex becomes
divided into regions with speciﬁc cytoarchitectures and func-
tions.
Pax6 is an Intrinsic Determinant of
Neuronal Fate in the Developing
Cortex
The observations that Pax6 is speciﬁcally expressed by radial
glial progenitor cells in the developing cortex and is required for
them to acquire their normal morphology, gene expression pat-
tern and cell cycle characteristics (Gotz et al., 1998), suggested
that Pax6 may control their ability to generate neurons. To
address this question, Heins et al. (2002) used a combination of
loss and gain of function approaches. They found that cultured
RGCs isolated from the developing cortex of Pax6−/− mutant
mouse embryos generated half as many pure neuronal clones
as RGCs from control embryos. Using a tau-GFP transgene to
label and quantify neurons by ﬂuorescence activated cell sort-
ing (FACS), they showed that the number of neurons in the
cortex of Pax6−/− mutant mouse embryos was reduced by half
at E14.5 and by a third at E16.5 compared to controls, consis-
tent with the previously reported thinner CP in Pax6−/− cortex
(Schmahl et al., 1993). Forced expression of Pax6 in cells disso-
ciated from E14 cortex or in astrocytes from postnatal cortex,
via transduction of a retroviral vector containing full length Pax6
cDNA, resulted in a signiﬁcant increase in the number of pure
neuronal clones generated, demonstrating that Pax6 is an intrin-
sic determinant of neuronal fate in murine cortical progenitors
(Heins et al., 2002). Mo and Zecevic (2008) showed that siRNA-
mediated knockdown of Pax6 expression in cultured human fetal
RGCs led to a signiﬁcant decrease in the number of neurons
produced, suggesting that the role of Pax6 in cortical neuroge-
nesis is maintained from rodents to humans (Mo and Zecevic,
2008).
TABLE 1 | Genes that have been identified as direct Pax6 targets in the mouse developing cortex grouped according to the developmental process that
they affect.
Process Gene Approach Reference
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Cell fate specification Etv1 (Er81) X X X X Tuoc and Stoykova (2008a), Sansom et al. (2009)
Olig2 X X Jang and Goldman (2011)
Isl1 X X Sansom et al. (2009), Xie et al. (2013)
Foxd1 X X Sansom et al. (2009)
Basal progenitor genesis Neurod1 X X Sansom et al. (2009)
Gadd45g X X Sansom et al. (2009)
Tbr2 X X X X Sansom et al. (2009), Tuoc et al. (2013a)
Neurogenesis Ngn2 X X X X Scardigli et al. (2003), Sansom et al. (2009)
Sox4 X X Sansom et al. (2009)
Sox11 X X Ninkovic et al. (2013)
Pou3f4 X X Ninkovic et al. (2013)
Nfib X X Ninkovic et al. (2013)
Cux1 X X X Tuoc et al. (2013a)
Tle1 X X X Tuoc et al. (2013a)
Cell cycle Cdk6 X X X Mi et al. (2013a)
Cdk4 X X Sansom et al. (2009)
Mcm3 X X Sansom et al. (2009)
Cdca2 X X Sansom et al. (2009)
Cdca7 X X Sansom et al. (2009)
P27kip1 X X Duparc et al. (2007)
Cell proliferation Pten X X Sansom et al. (2009)
Cdh1 X X Sansom et al. (2009)
Lix1 X X Sansom et al. (2009)
Hmga2 X X Sansom et al. (2009)
Fgfr1 X X Sansom et al. (2009)
Axonal transport Kif1b X X X Xie et al. (2013)
Unknown Snca X X Xie et al. (2013)
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Pax6 Confers both Regional and
Neurotransmitter Fates
The mammalian CP comprises mainly glutamatergic neurons
born in the cortical VZ and GABAergic interneurons (INs).
In mouse, most INs are born in the medial ganglionic emi-
nence (MGE; ∼70%) with others coming from the caudal
ganglionic eminence (CGE) and areas including the preoptic
area (POA; Anderson et al., 2001; Wonders and Anderson, 2006;
Fogarty et al., 2007; Gelman et al., 2009; Miyoshi et al., 2010). INs
born in the LGE populate the olfactory bulb (OB) and the
ventral telencephalon. Most cortical glutamatergic neurons and
GABAergic interneurons are generated between E12.5 and E16.5.
By E18.5, GABAergic INs are distributed throughout the cortex
of wild type embryos. In contrast, the cortex of Pax6−/− mutant
embryos contains large subpial ectopias composed of GABAergic
INs (Kroll and O’Leary, 2005). These ectopias develop from E15.5
onward and express markers of LGE-derived INs, including Sp8,
rather than markers of MGE-born INs, such as Lhx6. Their
development parallels a progressive ventralization of the dorsal
telencephalic VZ in Pax6−/− mutant embryos. At the start of
neurogenesis (E12.5–E13.5) the most ventrolateral part of the
Pax6−/− mutant cortex ectopically expresses the ventral telen-
cephalic markers Ascl1 and Gsh2. As neurogenesis progresses
ventral telencephalic identities extend dorsally such that by E14.5
most of the dorsal telencephalic VZ exhibits ventral charac-
teristics. This progressive ventralization is accompanied by a
dorsal shift in expression of markers of GABAergic INs such as
Dlx1/2 and GAD67. Importantly, the INs that form the ectopias
are derived from Emx1-expressing cortical progenitors which
normally generate glutamatergic neurons, demonstrating that
in Pax6−/− mutant mice, cortical progenitors are re-speciﬁed
to generate GABAergic INs instead of glutamatergic neurons
(Kroll and O’Leary, 2005).
Dlx1/2, Ascl1, and Gsh2 have been shown to promote
GABAergic fate, such as the expression of Gad67 (Long et al.,
2009a,b; Wang et al., 2013). Thus it is possible that Pax6 nor-
mally represses GABAergic identities in the cortex by blocking
the expression of these TFs.
In Pax6−/− embryos, early born CP neurons are cor-
rectly speciﬁed as dorsal telencephalic neurons, expressing dor-
sal markers Math2 and Tbr1 (Schuurmans et al., 2004). They
fail, however, to adopt a correct glutamatergic phenotype.
Interestingly, these early born neurons are not GABAergic either
(Schuurmans et al., 2004). Thus, during early corticogenesis,
Pax6 participates in the speciﬁcation of a correct glutamatergic
phenotype but is not required to suppress GABAergic identi-
ties. Schuurmans et al. (2004) analyzed double mutants for Ngn1
and Ngn2, and showed that, during early stages of cortico-
genesis (E13.5), neurogenins are required to specify a gluta-
matergic, cortical phenotype, and repress GABAergic identities.
Conversely, cortical neurons born at later stages of cortico-
genesis (E15.5) acquire a normal cortical and glutamatergic
phenotype in Ngn1−/−; Ngn2−/− double mutants whereas in
Pax6−/− embryos and in mutants lacking the orphan nuclear
receptor Tlx, they express reduced levels of cortical and glu-
tamatergic markers, compared to controls, and instead acquire
a subcortical, GABAergic phenotype (Schuurmans et al., 2004).
This study shows that distinct genetic programs operate during
early and late corticogenesis to specify cortical regional iden-
tity and neurotransmitter fate: neurogenins are required during
early stages while Pax6 and Tlx are required during later stages of
corticogenesis (Schuurmans et al., 2004).
Pax6 Confers Laminar Fate
Throughout corticogenesis, newborn neurons migrate to the CP
in an inside-out sequence such that deep layers are formed ﬁrst
and superﬁcial layers form later. The ﬁnal laminar position and
subtype of cortical projection neurons is dependent on the time
at which progenitors exit the cell cycle. In Pax6−/− mutant
embryos, the SVZ and superﬁcial cortical layers are defective,
as shown by absence of expression of Svet1 (which marks the
SVZ and superﬁcial layers), while the VZ and deep CP layers are
unaﬀected, as shown by the expression of Otx1 (Tarabykin et al.,
2001).
Examination of cortical lamination in Ngn1−/−; Ngn2−/−
mutants showed that the expression of markers of deep corti-
cal layers is reduced (Tbr1, Er81) while markers of superﬁcial
layers are expressed normally, indicating that late-born corti-
cal neurons are correctly speciﬁed (Schuurmans et al., 2004).
In contrast, no defects are detected in the deeper cortical lay-
ers of Pax6−/−, Tlx−/−, or Pax6−/−; Tlx−/− double mutants.
Markers of upper layers, however, are downregulated in Pax6
and Tlx single mutants and completely lost in Pax6−/−;Tlx−/−
embryos suggesting that Pax6 and Tlx cooperate to specify
the identity of late-born cortical neurons (Schuurmans et al.,
2004).
Study of cortical lamination in Pax6−/− mutants is lim-
ited by the fact that they die perinatally while cortical neu-
rons do not reach their ﬁnal location until around postnatal
day 8 (P8). Therefore, more recent studies on the role of Pax6
in cortical lamination have used conditional mutants in which
Pax6 is inactivated speciﬁcally in the cortex and at later stages
of cortical development and which survive postnatally. When
Pax6 was deleted speciﬁcally in the cortex from the onset of
corticogenesis, markers of superﬁcial layers were either down-
regulated or lost completely (Tuoc et al., 2009). In contrast,
when Pax6 was deleted in RGCs after the generation of deep
cortical layers (between E14.5 and E16.5) using an hGFAP-
cre transgenic line, the speciﬁcation and number of late born
neurons was unaﬀected (Tuoc et al., 2009), leading to the con-
clusion that Pax6 is not required for the speciﬁcation of late
born cortical neurons and that the defects of superﬁcial lay-
ers observed in Pax6−/− and Pax6cKO mutants are a result
of earlier defects in RGC proliferation. In a more recent study,
Georgala et al. (2011b) used an Emx1-creErT2 transgenic line
to remove Pax6 speciﬁcally in the cortex between E12.5 and
E13.5, before superﬁcial layer neurons are born. The result-
ing cKO mutant brains showed a dramatic reduction in the
thickness of the superﬁcial cortical layers, compared to con-
trol embryos. Late-born neurons were birth-dated by injecting
BrdU at E15.5 and stained for expression of Cux1, a marker of
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upper layer (II to IV) pyramidal neurons. There was a substantial
reduction in the number of E15.5 born neurons in the super-
ﬁcial cortical layers of the Pax6-cKO mutants and many fewer
late-born neurons expressed Cux1 (Georgala et al., 2011b), indi-
cating that Pax6 plays a crucial role in generation and speci-
ﬁcation of late born cortical neurons. Note that Pax6 protein
was lost slightly earlier in the conditional mutants generated by
Georgala et al. (2011b) than in those used by Tuoc et al. (2009),
potentially explaining the diﬀerence in outcomes between the two
studies.
Direct Transcriptional Targets of Pax6
Regulate Basal Progenitor Genesis,
Neurogenesis, and Cell Fate
Specification
Pax6 exerts many of its eﬀects, at least in part, by directly
regulating the expression of speciﬁc target genes (Table 1). As
described above, work in the mouse has shown that Pax6
expressing APs that give rise to BPs transiently express the
proneural TF Neurogenin 2 (Ngn2). BPs do not express Pax6
but do express the TF Tbr2. Loss of Pax6 function results in
loss of Ngn2 expression in the cortical VZ and downregula-
tion of Tbr2 in the SVZ (Stoykova et al., 2000; Toresson et al.,
2000; Yun et al., 2001; Scardigli et al., 2003; Holm et al., 2007;
Quinn et al., 2007; Sansom and Livesey, 2009), suggesting that
the development of BPs is impaired. Conversely, Pax6 overex-
pression results in a marked increase in both Ngn2 and Tbr2
expression (Scardigli et al., 2003; Sansom and Livesey, 2009),
each of which have been shown to be directly regulated by Pax6
(Scardigli et al., 2003; Sansom and Livesey, 2009; Tuoc et al.,
2013a). Scardigli et al. (2003) showed that Pax6 directly binds
and regulates the activity of the E1 enhancer of Ngn2, which
regulates Ngn2 expression in the cortex and the ventral spinal
cord.
Another direct target that is positively regulated by Pax6 is the
anti-neurogenic transcriptional co-repressor Tle1, a member of
the Groucho/transducin-like enhancer of split (Gro/Tle) family
(Sansom et al., 2009; Tuoc et al., 2013a). Gro/Tle proteins are
expressed in proliferating neural progenitor cells where they
promote maintenance of the undiﬀerentiated state by inhibit-
ing/delaying neuronal diﬀerentiation (Buscarlet and Stifani,
2007; Jennings and Ish-Horowicz, 2008).
Pax6 also directly inhibits the expression of Olig2
(Jang and Goldman, 2011), a TF critical for glial cell fate
determination (Marshall et al., 2005). Olig2 is expressed in a
subset of cells in the rat neonatal SVZ, which diﬀerentiate into
glia. Forced expression of Pax6 in these Olig2+ cells, using a
retrovirus, caused downregulation of Olig2 and a shift toward
neuronal fate (Jang and Goldman, 2011). These authors showed
that Pax6 can directly bind to Olig2’s promoter and repress its
activity.
Pax6 directly regulates markers of speciﬁc neuronal sub-
types including Er81 and Cux1 (Tuoc and Stoykova, 2008a;
Sansom et al., 2009; Tuoc et al., 2013a). Er81 is a TF expressed in
cortical progenitors, in a rostrolateral-high to caudomedial-low
gradient, and in a subset of pyramidal cells scattered through
layer 5 (Yoneshima et al., 2006; Tuoc and Stoykova, 2008a). In
the absence of Pax6, cortical progenitors do not express Er81
and the rostrolateral cortex lacks Er81 positive layer 5 neurons.
Cux1 is a marker of upper layer (II to IV) pyramidal neurons and
functions as a negative regulator of dendritic complexity for these
neurons (Cubelos et al., 2010, 2014; Li et al., 2010). As mentioned
above, loss of Pax6 results in a dramatic reduction of Cux1+
upper layer neurons, suggesting that the speciﬁcation of late born
neurons is impaired (Georgala et al., 2011b).
How does a single gene exert such a wide range of biologi-
cal eﬀects? Part of the answer to this question is suggested by
the ﬁndings that the Pax6 protein contains two distinct DNA-
binding domains, one of which is regulated by alternate splicing
and that Pax6 is able to interact with a number of co-factors,
which inﬂuence its activity. This issue is discussed in the next
section.
Complexity of Pax6 DNA-Binding
Properties and its Distinct Functions
Pax6 binds to target DNA sequences through one or both of
two DNA-binding domains, the paired domain (PD) and the
homeodomain (HD; Bertuccioli et al., 1996; Jun and Desplan,
1996; Sheng et al., 1997; Singh et al., 2000). Transcriptional reg-
ulation of Pax6 target genes is mediated by a carboxy termi-
nal proline/serine/threonine (PST) rich transactivation domain
(Singh et al., 1998, 2001; Tang et al., 1998; Figure 7).
FIGURE 7 | Schematic representation of functional domains in Pax6
and Pax6(5a) and their “optimal” DNA binding sites. (A) Pax6 and
Pax6(5a) differ in a 14 amino acid insertion in the PAI subdomain. (B)
“Optimal” DNA-binding sites for Pax6 PD, PD5a and HD. P6CON and 5aCON
sequences were generated by selection procedure (Epstein et al., 1994).
P6CON is recognized by monomeric PD, while 5aCON contains four binding
sites for PD5a that can bind up to four PD5a units. The “optimal” binding site
of Pax6 HD is a dimer with typical HD binding sequences (ATTA/TAAT)
separated by three nucleotides (G/T)CG (Czerny and Busslinger, 1995).
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The PD is an evolutionarily conserved 128 amino acid
DNA-binding domain shared by all members of the paired
box (Pax) family of TFs (Pax1-Pax9; Chalepakis et al., 1992;
Gruss and Walther, 1992). The Pax6 PD can be structurally and
functionally separated into two independent DNA-binding glob-
ular helix-turn-helix subdomains, PAI and RED (Puschel et al.,
1992; Czerny et al., 1993; Jun and Desplan, 1996; Figure 7A).
The well-established DNA-binding motif for canonical Pax6 PD,
known as P6CON, is a bipartite 20 base pair DNA sequence
whose 5′-half is recognized by the PAI subdomain and 3′-half
by the RED subdomain (Czerny et al., 1993; Epstein et al., 1994;
Figure 7A). The crystal structure of the Pax6 PD – P6CON com-
plex revealed direct interactions between both PAI and RED sub-
domains, the linker regions of PAI and RED subdomains and the
N-terminal β-turn subdomain with individual bases and phos-
phate residues of cognate DNA (Czerny et al., 1993; Epstein et al.,
1994; Xu et al., 1999a). Pax6 also contains an internal, paired-type
HD (Czerny et al., 1999; Eberhard and Busslinger, 1999) which
binds DNA in the form of a homodimer recognizing a symmetric
binding site (Wilson et al., 1993; Eberhard and Busslinger, 1999;
Mikkola et al., 2001; Figure 7B).
Although diﬀerent Pax6 DNA-binding domains can indepen-
dently bind to their “optimal” binding sites, using individual
consensus binding motif to predict and conﬁrm candidate Pax6-
binding sites has proven to be very diﬃcult (Shimoda et al.,
2002; Visel et al., 2007; Wolf et al., 2009). Unlike sequence spe-
ciﬁc DNA-binding proteins which harbor only one DNA-
binding domain, Pax6 exhibits increased DNA-binding complex-
ity because of its multiple DNA-binding subdomains (PAI, RED,
and HD) which can be used in varying combinations when bind-
ing to DNA (Cvekl et al., 2004; Grapp et al., 2009). A recent study
further reinforced the complexity of Pax6 DNA-binding proper-
ties by systematically examining coordinated actions of diﬀerent
Pax6 binding subdomains and identiﬁed a number of novel
variants of Pax6 DNA-binding motifs which can be bound by dif-
ferent combinations of Pax6 binding subdomains (Xie and Cvekl,
2011). As Pax6 can function either as a transcriptional activator or
repressor (Wolf et al., 2009), it is possible that some of these bind-
ing motif variants may induce structural changes in Pax6 proteins
that enable them to switch their function between transcriptional
activation and repression.
The complexity of the DNA binding properties of diﬀer-
ent Pax6 subdomains implies that the subregions exert distinct
functions during embryonic cortical development. Pax6 mutant
mouse lines with disruption of either the PD or the HD have been
used to investigate the impact of diﬀerent Pax6 binding domains
on telencephalic development. Haubst et al. (2004) showed that
the PD alone is necessary and suﬃcient for the regulation of
most aspects of telencephalic development including neurogene-
sis, progenitor cell proliferation, and patterning in the developing
cortex. In contrast, HD-speciﬁc mutations aﬀected only subtle
aspects of telencephalic development, such as establishment of
the PSPB, and had no obvious eﬀect on neurogenesis or pro-
liferation (Haubst et al., 2004). This suggests that the majority
of Pax6’s eﬀects during telencephalic development are mediated
by the PD with potentially diﬀerent contributions by its subdo-
mains. A recent study further dissected the roles of the diﬀerent
subdomains of the Pax6 PD during telencephalic development
by examining mice with point mutations in its individual sub-
domains PAI and RED (Walcher et al., 2013). This showed that
both PAI and RED act largely in a redundant manner in pattern-
ing of the telencephalon, with only the PAI mutation resulting in
the ectopic expression of subpallial genes such as Gsx2 and Olig2
into the pallium, suggesting that RED subdomain on its own is
not suﬃcient to regulate telencephalic patterning. In addition,
neurogenesis was aﬀected only by the PAI subdomain mutation,
phenocopying the neurogenic defects observed in full Pax6−/−
mutants. Strikingly, this study also revealed that subdomains
of Pax6 PD have distinct roles in regulating cortical progeni-
tor cell proliferation, with mutations aﬀecting the PAI and RED
subdomains respectively reducing and increasing the number of
mitoses.
Alternatively Spliced Isoforms of Pax6
and their Functions
In addition to Pax6 and Pax6(5a) a number of other splice vari-
ants of Pax6 have been reported, named p43, p33 and p32, each
of which is less abundant and mostly localized in the cyto-
plasm (Carriere et al., 1993; Jaworski et al., 1997; Pinson et al.,
2006). The 14 amino acid insertion in Pax6(5a) destroys the
DNA-binding capacity of the PAI subdomain, leaving the RED
subdomain of the PD and the intact HD for DNA binding
(Epstein et al., 1994; Kozmik et al., 1997). The PD in Pax6(5a)
binds to a distinct DNA sequence from that bound by the canon-
ical Pax6 PD, that has been named 5aCON (Epstein et al., 1994).
Direct comparison of the DNA binding sites recognized by Pax6
PD and PD(5a) showed partial sequence homology between the 3’
halves of P6CON and 5aCON (Epstein et al., 1994; Duncan et al.,
1998, 2000). This homology allows Pax6 (which contains the
canonical PD) to bind to both P6CON and 5aCON sites, whereas
Pax6(5a) can only interact with the 5aCON site (Epstein et al.,
1994).
The majority of published molecular studies have focused on
Pax6, as it contains the canonical PD and appears to be more
abundant than Pax6(5a) (Carriere et al., 1993; Richardson et al.,
1995; Koroma et al., 1997). During early development, Pax6 and
Pax6(5a) transcripts are expressed in a ratio of 8:1 in the mouse
forebrain, falling to 3:1 between E12.5 and E14.5 (Kozmik et al.,
1997; Pinson et al., 2006). A reduced ratio between Pax6
and Pax6(5a) was also seen during chick retina development
(Azuma et al., 2005). PAX6 and PAX6(5a) transcripts are equally
abundant in the human adult lens epithelium and cornea, as well
as in monkey retina (Zhang et al., 2001). These ﬁndings raise
the possibility that expression of the two main Pax6 isoforms
are regulated in a tissue- and temporal-speciﬁc manner, thereby
aﬀecting which target genes they recognize.
Although Pax6 and Pax6(5a) are commonly co-expressed,
there is evidence that they exert distinct functions during embry-
onic development. For example, overexpression of either Pax6
or Pax6(5a) in chick retina showed that both isoforms led
to increased retinal progenitor cell proliferation, but Pax6(5a)
induced ectopic diﬀerentiation of the retina to a stronger degree
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than Pax6 (Azuma et al., 2005). Similarly, Pax6(5a) strongly
induces neural diﬀerentiation of murine embryonic stem cells in
vitro, while Pax6 does not have such a strong eﬀect (Shimizu et al.,
2009). In the embryonic mouse forebrain, the diﬀerent roles of
the two Pax6 isoforms in regulation of cell proliferation and dif-
ferentiation were also established from studies of Pax6 mutants.
It was shown that mutations that abolish the binding property
of the PD aﬀect both proliferation and diﬀerentiation, while
a PD(5a) mutation only aﬀects proliferation and has no eﬀect
on cell fate/diﬀerentiation in mouse developing telencephalon
(Haubst et al., 2004). In a more recent study, Pax6(5a) speciﬁc
target genes were identiﬁed through microarray analyses of gene
expression proﬁles in cell lines stably expressing either Pax6 or
Pax6(5a) (Kiselev et al., 2012). This revealed that a number of
genes involved in cell proliferation, diﬀerentiation, and migra-
tion are diﬀerentially regulated by Pax6 and Pax6(5a), providing a
potential molecular basis by which Pax6 and Pax6(5a) could exert
their distinct biological functions.
Co-Factors Influence Pax6’s Direct
Regulation of Target Genes Involved in
Embryonic and Adult Neurogenesis
It is becoming clear that transcriptional regulation is highly
dependent on the molecular and cellular context, one reason
for which is that TFs do not act on their own but are depen-
dent on interactions with other co-factors to exert their functions
(Oikawa and Yamada, 2003;Westerman et al., 2003). These inter-
actions introduce more speciﬁcity into the regulatory function
of a given TF in a particular cellular context. A number co-
factors that can interact with Pax6 have been identiﬁed. For
example, Pax6 cooperates with Sox2 to target the lens-speciﬁc
enhancer of the δ-crystallin gene (Kamachi et al., 2001); with
MDIA to inﬂuence Pax6’s functions in cerebellar granule cells
(Tominaga et al., 2002); with Trim11 to mediate Pax6 degrada-
tion through the ubiquitin proteasome system (UPS) and mod-
ulate Pax6 transcriptional activity (Cooper and Hanson, 2005;
Tuoc and Stoykova, 2008b). More recently, Brg1/Brm associated
factors complex (BAF) and Meis2 have been identiﬁed as two
new co-factors that aﬀect Pax6’s direct regulation of target genes
expression, in turn regulating its role in both embryonic and
adult neurogenesis (Ninkovic et al., 2013; Tuoc et al., 2013a,b;
Agoston et al., 2014).
BAF Complex
A number of chromatin remodeling factors are known to play an
important role during mammalian neural development, includ-
ing the BAF complex (Ho et al., 2009a,b; Wu, 2012; Yip et al.,
2012; Tuoc et al., 2013a,b). Interestingly, the function of the BAF
complex in regulating neural development is dependent on its
subunit composition. In mammals, BAF complexes contain two
ATPase subunits Brg1 or Brm (Brahma), which are mutually
exclusive and essential for remodeling activity, in combination
with at least 15 diﬀerent BAF (Brg1/Brm-associated factor) sub-
units (Ho et al., 2009a; Singhal et al., 2010). Certain BAF subunits
have restricted expression patterns and thus could deﬁne tissue-
or cell-type-speciﬁc BAF complexes. For example, the compo-
sition of BAF complexes in ES cells (esBAF) is deﬁned by the
incorporation of Brg1 but not Brm, BAF155 but not BAF170,
and BAF60A but not BAF60C (Figure 8; Ho et al., 2009a,b).
However, during the transition from ES cells to neural pro-
genitors, the composition of BAF complexes is correspondingly
changed, deﬁning the neural progenitor speciﬁc BAF complex
(npBAF; Lessard et al., 2007; Yan et al., 2008; Ho et al., 2009a).
This process is accompanied by induction of BAF170 expression,
replacing one of the BAF155 subunits and the recruitment of Brm
as the ATP-ase subunit in the npBAF complex.
FIGURE 8 | Changes in subunit composition of BAF complexes during
differentiation from ES cells to neural progenitor cells. BAF complexes
undergo progressive changes in subunit composition during the transition from
embryonic stem cells (ESCs) to neural progenitor cells (NPCs). The BAF
complex in ESCs is called esBAF; in neuronal progenitors, npBAF. As ESCs
differentiate into NPCs, The esBAF complexes incorporate Brm and BAF170,
while excludes BAF60B and BAF155, thereby forming the neural
progenitor-specific BAF (npBAF) complexes in NPCs.
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In two recent studies, Tuoc et al. (2013a,b), described an ele-
gant model in which time-speciﬁc binding of BAF subunits
including BAF170, BAF155, and Brm-ATPase to Pax6 modu-
lates the expression of Pax6 target genes (Tbr2, Cux1, and Tle1)
involved in the speciﬁcation and generation of BPs and upper
layer neuronal fate in the developing cortex. Interestingly, this
model involves competition between BAF170 and BAF155 sub-
units in the BAF complex, which modulates chromatin modi-
ﬁcations and binding of the Pax6/REST co-repressor complex
to Pax6 target genes, thereby aﬀecting their expression. During
early neurogenesis (E12.5 to E14.5), the presence of BAF170 in
the Pax6-BAF complex prevents the euchromatin state (a lightly
packed form of chromatin) of the Pax6 target genes Tbr2, Cux1
and Tle1, limiting the ability of Pax6 to bind them, thereby
inhibiting their expression and promoting direct neurogenesis
(RGCs directly give rise to neurons) at this developmental stage.
In contrast, after E14.5 the expression of BAF170 decreases,
accompanied by enhanced expression of BAF155, leading to a
relaxed chromatin state of the promoters of the Pax6 target
genes mentioned above, thereby enhancing their expression and
in turn promoting indirect neurogenesis (RGCs indirectly give
rise to neurons through generating BPs). This study provides
novel insight into the interaction between BAF complex and Pax6
in the generation of BPs and the mode of neurogenesis in the
developing cortex. In another recent study, Ninkovic et al. (2013)
showed that Pax6 directly interacts with Brg1-ATPase of the BAF
complex to modulate expression of genes involved in neuronal
fate speciﬁcation in adult neural progenitors. This study indi-
cated that direct interaction of Pax6 with the Brg1/BAF complex
enhances the expression of Pax6 target neurogenic TFs including
Sox11, Nfib, and Pou3f4 which form a cross-regulatory network
driving neurogenic fate during adult neurogenesis. This study
improved our understanding of Pax6-mediated adult neuroge-
nesis and shed light on molecular mechanisms underlying the
function of Pax6 in cell fate speciﬁcation and conversion.
Meis2
Meis2 belongs to the TALE (three amino acid loop exten-
sion) family of atypical HD-containing TFs. It can form het-
eromeric complexes with other transcriptional regulators to
exert its functions during a range of biological processes
(Moskow et al., 1995; Chang et al., 1997; Knoepﬂer et al., 1999;
Moens and Selleri, 2006). Meis proteins control cell cycle pro-
gression and cell fate speciﬁcation of diﬀerent stem and progen-
itor cell types in a variety of tissues including liver, heart, retina,
and brain during development (Mercader et al., 1999; Hisa et al.,
2004; Bessa et al., 2008; Heine et al., 2008; Agoston and Schulte,
2009; Choe et al., 2009; Agoston et al., 2012, 2014; Paige et al.,
2012). Recently the functional importance of Meis2 in adult
neurogenesis has been discovered. It is involved in coordinated
actions with Pax6 (Agoston et al., 2014). During mouse adult
neurogenesis, Meis2 is strongly expressed in the SVZ and ros-
tral migratory stream (RMS) and in a subset of OB interneurons
(Agoston et al., 2014). Agoston et al. (2014) found that Meis2 can
physically interact with Pax6 in cells in the SVZ and OB. This
study also showed that the pro-neurogenic function of Pax6 in the
adult SVZ requires direct interaction with Meis2. Meis2 has tran-
scriptional activator function and Agoston et al. (2014) further
conﬁrmed that it acts as a Pax6 co-factor, binding to regulatory
elements of the Dcx gene to promote its expression during adult
SVZ neurogenesis.
Conclusion
The TF Pax6 is one of the most intensively studied high-level
developmental regulators, playing crucial roles in brain devel-
opment and implicated in disease. Numerous studies, including
those from our group, have shown that in both humans and
mice many abnormalities resulting frommutations in PAX6/Pax6
are in the cerebral cortex, where they arise largely because Pax6
is required for spatio-temporal control of many biological pro-
cesses including cortical stem and progenitor cell proliferation
and diﬀerentiation, neurogenesis, cell and laminar fate speciﬁca-
tion, neuronal migration, axon guidance and cortical arealization
during early corticogenesis. However, we are a long way from
having a comprehensive knowledge of exactly how Pax6 exerts
such complex actions. In particular, there are at least three major
challenges toward improved understanding of Pax6 functions.
First, how does such highly complex expression pattern of Pax6
come about? As described above, the transcriptional regulation
of Pax6 is particularly complex and involves both short-range
and long-range control mechanisms. Future studies are required
to gain better knowledge of tissue- and time-speciﬁc regulatory
elements responsible for spatiotemporally and quantitatively cor-
rect expression of Pax6. Secondly, how does Pax6 expression
level inﬂuence its functional outputs? Our studies along with
others have shown that Pax6 expression levels are crucial for
its functions such as regulating progenitor cell proliferation and
diﬀerentiation, and that mutations aﬀecting Pax6 protein levels
cause neurodevelopmental disorders in both humans and mice.
Now it is time to ask exactly how Pax6 levels inﬂuence its actions
at the molecular level. It will be of great interest to examine how
varying levels of Pax6 inﬂuence its molecular actions at diﬀer-
ent cell cycle phases, which will be critical to obtain a clearer
understanding of how Pax6 functions during the dynamics of cell
division. Finally and probably most importantly, we are still far
away from a comprehensive understanding of the complex gene
networks that Pax6 regulates and how these networks change spa-
tially and temporally during the course of cortical development.
This represents a major challenge since Pax6 likely exerts direct
and indirect regulation of diﬀerent sets of downstream genes
simultaneously, with context-dependent variation in the strength
of their positive or negative eﬀects.
Acknowledgments
Research in the authors’ laboratory was funded by the MRC
(MR/J003662/1). Human embryonic and fetal material was pro-
vided by the Joint MRC/Wellcome Trust (grant # 099175/Z/12/Z)
Human Developmental Biology Resource (www.hdbr.org).
Frontiers in Cellular Neuroscience | www.frontiersin.org 15 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
References
Agoston, Z., Heine, P., Brill, M. S., Grebbin, B. M., Hau, A. C., Kallenborn-
Gerhardt, W., et al. (2014). Meis2 is a Pax6 co-factor in neurogenesis and
dopaminergic periglomerular fate speciﬁcation in the adult olfactory bulb.
Development 141, 28–38. doi: 10.1242/dev.097295
Agoston, Z., Li, N., Haslinger, A., Wizenmann, A., and Schulte, D. (2012).
Genetic and physical interaction of Meis2, Pax3 and Pax7 during dor-
sal midbrain development. BMC Dev. Biol. 12:10. doi: 10.1186/1471-213X-
12-10
Agoston, Z., and Schulte, D. (2009). Meis2 competes with the Groucho co-
repressor Tle4 for binding to Otx2 and speciﬁes tectal fate without induction
of a secondary midbrain-hindbrain boundary organizer. Development 136,
3311–3322. doi: 10.1242/dev.037770
Anderson, S. A., Marin, O., Horn, C., Jennings, K., and Rubenstein, J. L. (2001).
Distinct cortical migrations from the medial and lateral ganglionic eminences.
Development 128, 353–363.
Angevine, J. B. Jr., and Sidman, R. L. (1961). Autoradiographic study of cell migra-
tion during histogenesis of cerebral cortex in the mouse. Nature 192, 766–768.
doi: 10.1038/192766b0
Aota, S., Nakajima, N., Sakamoto, R., Watanabe, S., Ibaraki, N., and Okazaki, K.
(2003). Pax6 autoregulation mediated by direct interaction of Pax6 protein with
the head surface ectoderm-speciﬁc enhancer of the mouse Pax6 gene.Dev. Biol.
257, 1–13. doi: 10.1016/S0012-1606(03)00058-7
Arai, Y., Pulvers, J. N., Haﬀner, C., Schilling, B., Nüsslein, I., Calegari,
F., et al. (2011). Neural stem and progenitor cells shorten S-phase on
commitment to neuron production. Nat. Commun. 2, 154. doi: 10.1038/
ncomms1155
Azuma, N., Tadokoro, K., Asaka, A., Yamada, M., Yamaguchi, Y., Handa, H., et al.
(2005). The Pax6 isoform bearing an alternative spliced exon promotes the
development of the neural retinal structure.Hum. Mol. Genet. 14, 735–745. doi:
10.1093/hmg/ddi069
Bamiou, D. E., Campbell, N. G., Musiek, F. E., Taylor, R., Chong, W. K., Moore,
A., et al. (2007a). Auditory and verbal working memory deﬁcits in a child with
congenital aniridia due to a PAX6 mutation. Int. J. Audiol. 46, 196–202. doi:
10.1080/14992020601175952
Bamiou, D. E., Free, S. L., Sisodiya, S. M., Chong, W. K., Musiek, F., Williamson,
K. A., et al. (2007b). Auditory interhemispheric transfer deﬁcits, hearing diﬃ-
culties, and brain magnetic resonance imaging abnormalities in children with
congenital aniridia due to PAX6 mutations. Arch. Pediatr. Adolesc. Med. 161,
463–469. doi: 10.1001/archpedi.161.5.463
Bamiou, D. E., Musiek, F. E., Sisodiya, S. M., Free, S. L., Davies, R. A., Moore, A.,
et al. (2004). Deﬁcient auditory interhemispheric transfer in patients with PAX6
mutations. Ann. Neurol. 56, 503–509. doi: 10.1002/ana.20227
Beaulieu, C. (1993). Numerical data on neocortical neurons in adult rat, with
special reference to the GABA population. Brain Res. 609, 284–292. doi:
10.1016/0006-8993(93)90884-P
Bel-Vialar, S., Medevielle, F., and Pituello, F. (2007). The on/oﬀ of Pax6 controls
the tempo of neuronal diﬀerentiation in the developing spinal cord. Dev. Biol.
305, 659–673. doi: 10.1016/j.ydbio.2007.02.012
Bentivoglio, M., and Mazzarello, P. (1999). The history of radial glia. Brain Res.
Bull. 49, 305–315. doi: 10.1016/S0361-9230(99)00065-9
Berger, J., Berger, S., Tuoc, T. C., D’amelio, M., Cecconi, F., Gorski, J. A., et al.
(2007). Conditional activation of Pax6 in the developing cortex of trans-
genic mice causes progenitor apoptosis. Development 134, 1311–1322. doi:
10.1242/dev.02809
Berry, M., and Rogers, A. W. (1965). The migration of neuroblasts in the develop-
ing cerebral cortex. J. Anat. 99, 691–709.
Bertuccioli, C., Fasano, L., Jun, S., Wang, S., Sheng, G., and Desplan, C. (1996).
In vivo requirement for the paired domain and homeodomain of the paired
segmentation gene product. Development 122, 2673–2685.
Bessa, J., Tavares, M. J., Santos, J., Kikuta, H., Laplante, M., Becker, T. S.,
et al. (2008). meis1 regulates cyclin D1 and c-myc expression, and con-
trols the proliferation of the multipotent cells in the early developing
zebraﬁsh eye. Development 135, 799–803. doi: 10.1242/dev.011932 dev.
011932
Betizeau, M., Cortay, V., Patti, D., Pﬁster, S., Gautier, E., Bellemin-Menard,
A., et al. (2013). Precursor diversity and complexity of lineage relationships
in the outer subventricular zone of the primate. Neuron 80, 442–457. doi:
10.1016/j.neuron.2013.09.032 S0896-6273(13)00863-5
Bishop, K. M., Goudreau, G., and O’leary, D. D. (2000). Regulation of area iden-
tity in the mammalian neocortex by Emx2 and Pax6. Science 288, 344–349. doi:
10.1126/science.288.5464.344
Bishop, K. M., Rubenstein, J. L., and O’leary, D. D. (2002). Distinct actions of
Emx1, Emx2, and Pax6 in regulating the speciﬁcation of areas in the developing
neocortex. J. Neurosci. 22, 7627–7638.
Britz, O., Mattar, P., Nguyen, L., Langevin, L. M., Zimmer, C., Alam, S., et al. (2006).
A role for proneural genes in the maturation of cortical progenitor cells. Cereb.
Cortex 16(Suppl. 1), i138–i151. doi: 10.1093/cercor/bhj168
Buscarlet, M., and Stifani, S. (2007). The ‘Marx’ of Groucho on development and
disease. Trends Cell Biol. 17, 353–361. doi: 10.1016/j.tcb.2007.07.002
Cameron, R. S., and Rakic, P. (1991). Glial cell lineage in the cerebral cortex: a
review and synthesis. Glia 4, 124–137. doi: 10.1002/glia.440040204
Caric, D., Gooday, D., Hill, R. E., Mcconnell, S. K., and Price, D. J. (1997).
Determination of the migratory capacity of embryonic cortical cells lacking the
transcription factor Pax-6. Development 124, 5087–5096.
Carriere, C., Plaza, S., Martin, P., Quatannens, B., Bailly, M., Stehelin, D., et al.
(1993). Characterization of quail Pax-6 (Pax-QNR) proteins expressed in the
neuroretina.Mol. Cell. Biol. 13, 7257–7266. doi: 10.1128/MCB.13.12.7257
Cartier, L., Laforge, T., Feki, A., Arnaudeau, S., Dubois-Dauphin, M., and Krause,
K. H. (2006). Pax6-induced alteration of cell fate: shape changes, expression of
neuronal alpha tubulin, postmitotic phenotype, and cell migration. J. Neurobiol.
66, 421–436. doi: 10.1002/neu.20225
Chalepakis, G., Tremblay, P., and Gruss, P. (1992). Pax genes, mutants andmolecu-
lar function. J. Cell Sci. Suppl. 16, 61–67. doi: 10.1242/jcs.1992.Supplement_16.8
Chang, C. P., Jacobs, Y., Nakamura, T., Jenkins, N. A., Copeland, N. G., and
Cleary, M. L. (1997). Meis proteins are major in vivo DNA binding partners
for wild-type but not chimeric Pbx proteins.Mol. Cell. Biol. 17, 5679–5687.
Choe, S. K., Lu, P., Nakamura, M., Lee, J., and Sagerstrom, C. G. (2009).
Meis cofactors control HDAC and CBP accessibility at Hox-regulated
promoters during zebraﬁsh embryogenesis. Dev. Cell 17, 561–567. doi:
10.1016/j.devcel.2009.08.007
Chow, R. L., Altmann, C. R., Lang, R. A., and Hemmati-Brivanlou, A. (1999). Pax6
induces ectopic eyes in a vertebrate.Development 126, 4213–4222.
Cooper, S. T., and Hanson, I. M. (2005). A screen for proteins that interact with
PAX6: C-terminal mutations disrupt interaction with HOMER3, DNCL1 and
TRIM11. BMC Genet. 6:43. doi: 10.1186/1471-2156-6-43
Crolla, J. A., and van Heyningen, V. (2002). Frequent chromosome aberrations
revealed by molecular cytogenetic studies in patients with aniridia. Am. J. Hum.
Genet. 71, 1138–1149. doi: 10.1086/344396
Cubelos, B., Briz, C. G., Esteban-Ortega, G. M., and Nieto, M. (2014). Cux1 and
Cux2 selectively target basal and apical dendritic compartments of layer II-III
cortical neurons. Dev. Neurobiol. 75, 163–172. doi: 10.1002/dneu.22215
Cubelos, B., Sebastian-Serrano, A., Beccari, L., Calcagnotto, M. E., Cisneros, E.,
Kim, S., et al. (2010). Cux1 and Cux2 regulate dendritic branching, spine mor-
phology, and synapses of the upper layer neurons of the cortex. Neuron 66,
523–535. doi: 10.1016/j.neuron.2010.04.038
Cvekl, A., Yang, Y., Chauhan, B. K., and Cveklova, K. (2004). Regulation of gene
expression by Pax6 in ocular cells: a case of tissue-preferred expression of
crystallins in lens. Int. J. Dev. Biol. 48, 829–844. doi: 10.1387/ijdb.041866ac
Czerny, T., and Busslinger, M. (1995). DNA-binding and transactivation proper-
ties of Pax-6: three amino acids in the paired domain are responsible for the
diﬀerent sequence recognition of Pax-6 and BSAP (Pax-5). Mol. Cell. Biol. 15,
2858–2871.
Czerny, T., Halder, G., Kloter, U., Souabni, A., Gehring, W. J., and Busslinger,
M. (1999). twin of eyeless, a second Pax-6 gene of Drosophila, acts upstream
of eyeless in the control of eye development. Mol. Cell 3, 297–307. doi:
10.1016/S1097-2765(00)80457-8
Czerny, T., Schaﬀner, G., and Busslinger, M. (1993). DNA sequence recognition by
Pax proteins: bipartite structure of the paired domain and its binding site.Genes
Dev. 7, 2048–2061. doi: 10.1101/gad.7.10.2048
Davis, L. K., Meyer, K. J., Rudd, D. S., Librant, A. L., Epping, E. A., Sheﬃeld, V. C.,
et al. (2008). Pax6 3’ deletion results in aniridia, autism and mental retardation.
Hum. Genet. 123, 371–378. doi: 10.1007/s00439-008-0484-x
Dehay, C., and Kennedy, H. (2007). Cell-cycle control and cortical development.
Nat. Rev. Neurosci. 8, 438–450. doi: 10.1038/nrn2097
Frontiers in Cellular Neuroscience | www.frontiersin.org 16 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
Dominguez, M., Ferres-Marco, D., Gutierrez-Avino, F. J., Speicher, S. A., and
Beneyto, M. (2004). Growth and speciﬁcation of the eye are controlled inde-
pendently by Eyegone and Eyeless in Drosophila melanogaster. Nat. Genet. 36,
31–39. doi: 10.1038/ng1281
Duncan, M. K., Cvekl, A., Li, X., and Piatigorsky, J. (2000). Truncated forms of
Pax-6 disrupt lens morphology in transgenic mice. Invest. Ophthalmol. Vis. Sci.
41, 464–473.
Duncan, M. K., Haynes, J. I., Cvekl, A., and Piatigorsky, J. (1998). Dual roles for
Pax-6: a transcriptional repressor of lens ﬁber cell-speciﬁc beta-crystallin genes.
Mol. Cell. Biol. 18, 5579–5586.
Duparc, R. H., Abdouh, M., David, J., Lepine, M., Tetreault, N., and Bernier,
G. (2007). Pax6 controls the proliferation rate of neuroepithelial pro-
genitors from the mouse optic vesicle. Dev. Biol. 301, 374–387. doi:
10.1016/j.ydbio.2006.11.006
Eberhard, D., and Busslinger, M. (1999). The partial homeodomain of the tran-
scription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and
TATA-binding proteins. Cancer Res. 59(Suppl. 7), 1716s–1724s.
Ellison-Wright, Z., Heyman, I., Frampton, I., Rubia, K., Chitnis, X., Ellison-Wright,
I., et al. (2004). Heterozygous PAX6 mutation, adult brain structure and fronto-
striato-thalamic function in a human family. Eur. J. Neurosci. 19, 1505–1512.
doi: 10.1111/j.1460-9568.2004.03236.x
Englund, C., Fink, A., Lau, C., Pham, D., Daza, R. A., Bulfone, A.,
et al. (2005). Pax6, Tbr2, and Tbr1 are expressed sequentially by radial
glia, intermediate progenitor cells, and postmitotic neurons in develop-
ing neocortex. J. Neurosci. 25, 247–251. doi: 10.1523/JNEUROSCI.2899-
04.2005
Epstein, J., Cai, J., Glaser, T., Jepeal, L., and Maas, R. (1994). Identiﬁcation of
a Pax paired domain recognition sequence and evidence for DNA-dependent
conformational changes. J. Biol. Chem. 269, 8355–8361.
Estivill-Torrus, G., Pearson, H., Van Heyningen, V., Price, D. J., and Rashbass, P.
(2002). Pax6 is required to regulate the cell cycle and the rate of progression
from symmetrical to asymmetrical division in mammalian cortical progenitors.
Development 129, 455–466.
Fantes, J., Redeker, B., Breen, M., Boyle, S., Brown, J., Fletcher, J., et al.
(1995). Aniridia-associated cytogenetic rearrangements suggest that a position
eﬀect may cause the mutant phenotype. Hum. Mol. Genet. 4, 415–422. doi:
10.1093/hmg/4.3.415
Farkas, L. M., and Huttner, W. B. (2008). The cell biology of neural stem and pro-
genitor cells and its signiﬁcance for their proliferation versus diﬀerentiation
during mammalian brain development. Curr. Opin. Cell Biol. 20, 707–715. doi:
10.1016/j.ceb.2008.09.008
Fietz, S. A., Kelava, I., Vogt, J., Wilsch-Brauninger, M., Stenzel, D., Fish, J. L., et al.
(2010). OSVZ progenitors of human and ferret neocortex are epithelial-like and
expand by integrin signaling. Nat. Neurosci. 13, 690–699. doi: 10.1038/nn.2553
nn.2553
Florio, M., and Huttner, W. B. (2014). Neural progenitors, neurogenesis
and the evolution of the neocortex. Development 141, 2182–2194. doi:
10.1242/dev.090571 141/11/2182
Fogarty, M., Grist, M., Gelman, D., Marin, O., Pachnis, V., and Kessaris,
N. (2007). Spatial genetic patterning of the embryonic neuroepithe-
lium generates GABAergic interneuron diversity in the adult cortex.
J. Neurosci. 27, 10935–10946. doi: 10.1523/JNEUROSCI.1629-07.
2007
Free, S. L., Mitchell, T. N., Williamson, K. A., Churchill, A. J., Shorvon,
S. D., Moore, A. T., et al. (2003). Quantitative MR image analysis in
subjects with defects in the PAX6 gene. Neuroimage 20, 2281–2290. doi:
10.1016/j.neuroimage.2003.07.001
Fukushima, Y., Hoovers, J., Mannens, M., Wakui, K., Ohashi, H., Ohno, T., et al.
(1993). Detection of a cryptic paracentric inversionwithin band 11p13 in famil-
ial aniridia by ﬂuorescence in situ hybridization.Hum. Genet. 91, 205–209. doi:
10.1007/BF00218257
Gal, J. S., Morozov, Y. M., Ayoub, A. E., Chatterjee, M., Rakic, P., and Haydar,
T. F. (2006). Molecular and morphological heterogeneity of neural precursors
in the mouse neocortical proliferative zones. J. Neurosci. 26, 1045–1056. doi:
10.1523/JNEUROSCI.4499-05.2006
Gelman, D. M., and Marin, O. (2010). Generation of interneuron diversity in the
mouse cerebral cortex. Eur. J. Neurosci. 31, 2136–2141. doi: 10.1111/j.1460-
9568.2010.07267.x
Gelman, D. M., Martini, F. J., Nobrega-Pereira, S., Pierani, A., Kessaris,
N., and Marin, O. (2009). The embryonic preoptic area is a novel
source of cortical GABAergic interneurons. J. Neurosci. 29, 9380–9389. doi:
10.1523/JNEUROSCI.0604-09.2009
Georgala, P. A., Carr, C. B., and Price, D. J. (2011a). The role of Pax6
in forebrain development. Dev. Neurobiol. 71, 690–709. doi: 10.1002/dneu.
20895
Georgala, P. A., Manuel, M., and Price, D. J. (2011b). The generation of superﬁ-
cial cortical layers is regulated by levels of the transcription factor Pax6. Cereb.
Cortex 21, 81–94. doi: 10.1093/cercor/bhq061
Gillies,K., and Price, D. J. (1993). The fates of cells in the developing cerebral cortex
of normal and methylazoxymethanol acetate-lesioned mice. Eur. J. Neurosci. 5,
73–84. doi: 10.1111/j.1460-9568.1993.tb00207.x
Glaser, T., Jepeal, L., Edwards, J. G., Young, S. R., Favor, J., and Maas, R. L.
(1994). PAX6 gene dosage eﬀect in a family with congenital cataracts, aniridia,
anophthalmia and central nervous system defects. Nat. Genet. 7, 463–471. doi:
10.1038/ng0894-463
Glaser, T., Walton, D. S., and Maas, R. L. (1992). Genomic structure, evolutionary
conservation and aniridia mutations in the human PAX6 gene. Nat. Genet. 2,
232–239. doi: 10.1038/ng1192-232
Gotz, M., Stoykova, A., and Gruss, P. (1998). Pax6 controls radial glia diﬀer-
entiation in the cerebral cortex. Neuron 21, 1031–1044. doi: 10.1016/S0896-
6273(00)80621-2
Grapp, M., Teichler, S., Kitz, J., Dibaj, P., Dickel, C., Knepel, W., et al. (2009).
The homeodomain of PAX6 is essential for PAX6-dependent activation of
the rat glucagon gene promoter: evidence for a PH0-like binding that
induces an active conformation. Biochim. Biophys. Acta 1789, 403–412. doi:
10.1016/j.bbagrm.2009.02.001
Griﬃn, C., Kleinjan, D. A., Doe, B., and Van Heyningen, V. (2002). New 3’
elements control Pax6 expression in the developing pretectum, neural retina
and olfactory region. Mech. Dev. 112, 89–100. doi: 10.1016/S0925-4773(01)
00646-3
Gruss, P., and Walther, C. (1992). Pax in development. Cell 69, 719–722. doi:
10.1016/0092-8674(92)90281-G
Hack, M. A., Sugimori, M., Lundberg, C., Nakafuku, M., and Gotz, M. (2004).
Regionalization and fate speciﬁcation in neurospheres: the role of Olig2
and Pax6. Mol. Cell. Neurosci. 25, 664–678. doi: 10.1016/j.mcn.2003.12.012
S1044743103003956
Hansen, D. V., Lui, J. H., Flandin, P., Yoshikawa, K., Rubenstein, J. L., Alvarez-
Buylla, A., et al. (2013). Non-epithelial stem cells and cortical interneuron
production in the human ganglionic eminences. Nat. Neurosci. 16, 1576–1587.
doi: 10.1038/nn.3541
Hansen, D. V., Lui, J. H., Parker, P. R., and Kriegstein, A. R. (2010). Neurogenic
radial glia in the outer subventricular zone of human neocortex. Nature 464,
554–561. doi: 10.1038/nature08845
Hatten, M. E. (2002). New directions in neuronal migration. Science 297, 1660–
1663. doi: 10.1126/science.1074572
Haubensak, W., Attardo, A., Denk, W., and Huttner, W. B. (2004). Neurons
arise in the basal neuroepithelium of the early mammalian telencephalon: a
major site of neurogenesis. Proc. Natl. Acad. Sci. U.S.A. 101, 3196–3201. doi:
10.1073/pnas.0308600100
Haubst, N., Berger, J., Radjendirane, V., Graw, J., Favor, J., Saunders, G. F.,
et al. (2004). Molecular dissection of Pax6 function: the speciﬁc roles of the
paired domain and homeodomain in brain development. Development 131,
6131–6140. doi: 10.1242/dev.01524
Hauck, B., Gehring, W. J., and Walldorf, U. (1999). Functional analysis of an eye
speciﬁc enhancer of the eyeless gene in Drosophila. Proc. Natl. Acad. Sci. U.S.A.
96, 564–569. doi: 10.1073/pnas.96.2.564
Haydar, T. F., Ang, E. Jr., and Rakic, P. (2003). Mitotic spindle rotation and mode
of cell division in the developing telencephalon. Proc. Natl. Acad. Sci. U.S.A.
100, 2890–2895. doi: 10.1073/pnas.04379691000437969100
Heine, P., Dohle, E., Bumsted-O’brien, K., Engelkamp, D., and Schulte, D.
(2008). Evidence for an evolutionary conserved role of homothorax/Meis1/2
during vertebrate retina development. Development 135, 805–811. doi:
10.1242/dev.012088
Heins, N., Malatesta, P., Cecconi, F., Nakafuku, M., Tucker, K. L., Hack, M. A.,
et al. (2002). Glial cells generate neurons: the role of the transcription factor
Pax6. Nat. Neurosci. 5, 308–315. doi: 10.1038/nn828
Frontiers in Cellular Neuroscience | www.frontiersin.org 17 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
Hendry, S. H., Schwark, H. D., Jones, E. G., and Yan, J. (1987). Numbers and
proportions of GABA-immunoreactive neurons in diﬀerent areas of monkey
cerebral cortex. J. Neurosci. 7, 1503–1519.
Hevner, R. F. (2006). From radial glia to pyramidal-projection neuron: transcrip-
tion factor cascades in cerebral cortex development.Mol. Neurobiol. 33, 33–50.
doi: 10.1385/MN:33:1:033
Hingorani, M., Williamson, K. A., Moore, A. T., and Van Heyningen, V. (2009).
Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations.
Invest. Ophthalmol. Vis. Sci. 50, 2581–2590. doi: 10.1167/iovs.08-2827
Hisa, T., Spence, S. E., Rachel, R. A., Fujita, M., Nakamura, T., Ward, J. M., et al.
(2004). Hematopoietic, angiogenic and eye defects in Meis1 mutant animals.
EMBO J. 23, 450–459. doi: 10.1038/sj.emboj.7600038
Ho, L., Jothi, R., Ronan, J. L., Cui, K., Zhao, K., and Crabtree, G. R. (2009a).
An embryonic stem cell chromatin remodeling complex, esBAF, is an essential
component of the core pluripotency transcriptional network. Proc. Natl. Acad.
Sci. U.S.A. 106, 5187–5191. doi: 10.1073/pnas.0812888106
Ho, L., Ronan, J. L., Wu, J., Staahl, B. T., Chen, L., Kuo, A., et al. (2009b). An
embryonic stem cell chromatin remodeling complex, esBAF, is essential for
embryonic stem cell self-renewal and pluripotency. Proc. Natl. Acad. Sci. U.S.A.
106, 5181–5186. doi: 10.1073/pnas.0812889106
Holm, P. C., Mader, M. T., Haubst, N., Wizenmann, A., Sigvardsson, M., and
Gotz, M. (2007). Loss- and gain-of-function analyses reveal targets of Pax6
in the developing mouse telencephalon. Mol. Cell Neurosci. 34, 99–119. doi:
10.1016/j.mcn.2006.10.008
Huttner, W. B., and Kosodo, Y. (2005). Symmetric versus asymmetric cell division
during neurogenesis in the developing vertebrate central nervous system. Curr.
Opin. Cell Biol. 17, 648–657. doi: 10.1016/j.ceb.2005.10.005
Jakovcevski, I., Mayer, N., and Zecevic, N. (2011). Multiple origins of
human neocortical interneurons are supported by distinct expression of
transcription factors. Cereb. Cortex 21, 1771–1782. doi: 10.1093/cercor/
bhq245
Jang, E. S., and Goldman, J. E. (2011). Pax6 expression is suﬃcient to induce a neu-
rogenic fate in glial progenitors of the neonatal subventricular zone. PLoS ONE
6:e20894. doi: 10.1371/journal.pone.0020894
Jaworski, C., Sperbeck, S., Graham, C., and Wistow, G. (1997). Alternative splic-
ing of Pax6 in bovine eye and evolutionary conservation of intron sequences.
Biochem. Biophys. Res. Commun. 240, 196–202. doi: 10.1006/bbrc.1997.7623
Jennings, B. H., and Ish-Horowicz, D. (2008). The Groucho/TLE/Grg family of
transcriptional co-repressors. Genome Biol. 9, 205. doi: 10.1186/gb-2008-9-1-
205gb
Jun, S., and Desplan, C. (1996). Cooperative interactions between paired domain
and homeodomain. Development 122, 2639–2650.
Kaldis, P., and Richardson, H. E. (2012). When cell cycle meets development.
Development 139, 225–230. doi: 10.1242/dev.073288
Kamachi, Y., Uchikawa, M., Tanouchi, A., Sekido, R., and Kondoh, H. (2001). Pax6
and SOX2 form a co-DNA-binding partner complex that regulates initiation of
lens development.Genes Dev. 15, 1272–1286. doi: 10.1101/gad.887101
Kammandel, B., Chowdhury, K., Stoykova, A., Aparicio, S., Brenner, S., and Gruss,
P. (1999). Distinct cis-essential modules direct the time-space pattern of the
Pax6 gene activity. Dev. Biol. 205, 79–97. doi: 10.1006/dbio.1998.9128
Kerwin, J., Yang, Y., Merchan, P., Sarma, S., Thompson, J., Wang, X., et al. (2010).
The HUDSEN Atlas: a three-dimensional (3D) spatial framework for study-
ing gene expression in the developing human brain. J. Anat. 217, 289–299. doi:
10.1111/j.1469-7580.2010.01290.x
Kiecker, C., and Lumsden, A. (2005). Compartments and their boundaries in verte-
brate brain development.Nat. Rev. Neurosci. 6, 553–564. doi: 10.1038/nrn1702
Kim, J., and Lauderdale, J. D. (2006). Analysis of Pax6 expression using a
BAC transgene reveals the presence of a paired-less isoform of Pax6 in the
eye and olfactory bulb. Dev. Biol. 292, 486–505. doi: 10.1016/j.ydbio.2005.
12.041
Kiselev, Y., Eriksen, T. E., Forsdahl, S., Nguyen, L. H., and Mikkola, I. (2012). 3T3
cell lines stably expressing Pax6 or Pax6(5a)–a new tool used for identiﬁca-
tion of common and isoform speciﬁc target genes. PLoS ONE 7:e31915. doi:
10.1371/journal.pone.0031915
Kleinjan, D. A., Seawright, A., Childs, A. J., and Van Heyningen, V. (2004).
Conserved elements in Pax6 intron 7 involved in (auto)regulation and
alternative transcription. Dev. Biol. 265, 462–477. doi: 10.1016/j.ydbio.2003.
09.011
Kleinjan, D. A., Seawright, A., Elgar, G., and Van Heyningen, V. (2002).
Characterization of a novel gene adjacent to PAX6, revealing synteny con-
servation with functional signiﬁcance. Mamm. Genome 13, 102–107. doi:
10.1007/s00335-001-3058-y
Kleinjan, D. A., Seawright, A., Mella, S., Carr, C. B., Tyas, D. A., Simpson, T. I., et al.
(2006). Long-range downstream enhancers are essential for Pax6 expression.
Dev. Biol. 299, 563–581. doi: 10.1016/j.ydbio.2006.08.060
Kleinjan, D. A., Seawright, A., Schedl, A., Quinlan, R. A., Danes, S.,
and Van Heyningen, V. (2001). Aniridia-associated translocations, DNase
hypersensitivity, sequence comparison and transgenic analysis redeﬁne
the functional domain of PAX6. Hum. Mol. Genet. 10, 2049–2059. doi:
10.1093/hmg/10.19.2049
Knoepﬂer, P. S., Bergstrom, D. A., Uetsuki, T., Dac-Korytko, I., Sun, Y. H.,
Wright, W. E., et al. (1999). A conserved motif N-terminal to the DNA-
binding domains of myogenic bHLH transcription factors mediates cooperative
DNA binding with pbx-Meis1/Prep1. Nucleic Acids Res. 27, 3752–3761. doi:
10.1093/nar/27.18.3752
Kornack, D. R., and Rakic, P. (1998). Changes in cell-cycle kinetics during the
development and evolution of primate neocortex. Proc. Natl. Acad. Sci. U.S.A.
95, 1242–1246. doi: 10.1073/pnas.95.3.1242
Koroma, B. M., Yang, J. M., and Sundin, O. H. (1997). The Pax-6 homeobox
gene is expressed throughout the corneal and conjunctival epithelia. Invest.
Ophthalmol. Vis. Sci. 38, 108–120.
Kozmik, Z., Czerny, T., and Busslinger, M. (1997). Alternatively spliced insertions
in the paired domain restrict the DNA sequence speciﬁcity of Pax6 and Pax8.
EMBO J. 16, 6793–6803. doi: 10.1093/emboj/16.22.6793
Kroll, T. T., and O’Leary, D. D. (2005). Ventralized dorsal telencephalic pro-
genitors in Pax6 mutant mice generate GABA interneurons of a lateral gan-
glionic eminence fate. Proc. Natl. Acad. Sci. U.S.A. 102, 7374–7379. doi:
10.1073/pnas.0500819102
Krubitzer, L., and Kaas, J. (2005). The evolution of the neocortex in mammals:
how is phenotypic diversity generated? Curr. Opin. Neurobiol. 15, 444–453. doi:
10.1016/j.conb.2005.07.003
Lauderdale, J. D., Wilensky, J. S., Oliver, E. R., Walton, D. S., and Glaser, T. (2000).
3’ deletions cause aniridia by preventing PAX6 gene expression. Proc. Natl.
Acad. Sci. U.S.A. 97, 13755–13759. doi: 10.1073/pnas.240398797
Lessard, J., Wu, J. I., Ranish, J. A., Wan, M., Winslow, M. M., Staahl, B. T.,
et al. (2007). An essential switch in subunit composition of a chromatin
remodeling complex during neural development. Neuron 55, 201–215. doi:
10.1016/j.neuron.2007.06.019
Letinic, K., Zoncu, R., and Rakic, P. (2002). Origin of GABAergic neurons in the
human neocortex. Nature 417, 645–649. doi: 10.1038/nature00779
Levers, T. E., Edgar, J. M., and Price, D. J. (2001). The fates of cells generated at the
end of neurogenesis in developingmouse cortex. J. Neurobiol. 48, 265–277. doi:
10.1002/neu.1056
Levitt, P., and Rakic, P. (1980). Immunoperoxidase localization of glial ﬁb-
rillary acidic protein in radial glial cells and astrocytes of the developing
rhesus monkey brain. J. Comp. Neurol. 193, 815–840. doi: 10.1002/cne.9019
30316
Li, N., Zhao, C. T., Wang, Y., and Yuan, X. B. (2010). The transcription factor
Cux1 regulates dendritic morphology of cortical pyramidal neurons. PLoS ONE
5:e10596. doi: 10.1371/journal.pone.0010596
Long, J. E., Cobos, I., Potter, G. B., and Rubenstein, J. L. (2009a). Dlx1&2 and
Mash1 transcription factors control MGE and CGE patterning and diﬀeren-
tiation through parallel and overlapping pathways. Cereb. Cortex 19(Suppl. 1),
i96–i106. doi: 10.1093/cercor/bhp045bhp045
Long, J. E., Swan, C., Liang, W. S., Cobos, I., Potter, G. B., and Rubenstein, J. L.
(2009b). Dlx1&2 and Mash1 transcription factors control striatal patterning
and diﬀerentiation through parallel and overlapping pathways. J. Comp. Neurol.
512, 556–572. doi: 10.1002/cne.21854
Lukaszewicz, A., Savatier, P., Cortay, V., Giroud, P., Huissoud, C., Berland,
M., et al. (2005). G1 phase regulation, area-speciﬁc cell cycle control,
and cytoarchitectonics in the primate cortex. Neuron 47, 353–364. doi:
10.1016/j.neuron.2005.06.032
Maekawa, M., Iwayama, Y., Nakamura, K., Sato, M., Toyota, T., Ohnishi, T., et al.
(2009). A novel missense mutation (Leu46Val) of PAX6 found in an autistic
patient. Neurosci. Lett. 462, 267–271. doi: 10.1016/j.neulet.2009.07.021S0304-
3940(09)00939-2
Frontiers in Cellular Neuroscience | www.frontiersin.org 18 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
Malandrini, A., Mari, F., Palmeri, S., Gambelli, S., Berti, G., Bruttini, M., et al.
(2001). PAX6 mutation in a family with aniridia, congenital ptosis, and
mental retardation. Clin. Genet. 60, 151–154. doi: 10.1034/j.1399-0004.2001.
600210.x
Malatesta, P., Hack, M. A., Hartfuss, E., Kettenmann, H., Klinkert, W., Kirchhoﬀ,
F., et al. (2003). Neuronal or glial progeny: regional diﬀerences in radial glia
fate. Neuron 37, 751–764. doi: 10.1016/S0896-6273(03)00116-8
Malatesta, P., Hartfuss, E., and Gotz, M. (2000). Isolation of radial glial cells by
ﬂuorescent-activated cell sorting reveals a neuronal lineage. Development 127,
5253–5263.
Malumbres, M., and Barbacid, M. (2001). To cycle or not to cycle: a critical decision
in cancer. Nat. Rev. Cancer 1, 222–231. doi: 10.1038/35106065
Malumbres, M., and Barbacid, M. (2005). Mammalian cyclin-dependent kinases.
Trends Biochem. Sci. 30, 630–641. doi: 10.1016/j.tibs.2005.09.005
Mansouri, A., Stoykova, A., and Gruss, P. (1994). Pax genes in development. J. Cell
Sci. Suppl. 18, 35–42. doi: 10.1242/jcs.1994.Supplement_18.5
Manuel, M., Georgala, P. A., Carr, C. B., Chanas, S., Kleinjan, D. A., Martynoga, B.,
et al. (2007). Controlled overexpression of Pax6 in vivo negatively autoregulates
the Pax6 locus, causing cell-autonomous defects of late cortical progenitor pro-
liferation with little eﬀect on cortical arealization. Development 134, 545–555.
doi: 10.1242/dev.02764
Marquardt, T., Ashery-Padan, R., Andrejewski, N., Scardigli, R., Guillemot, F., and
Gruss, P. (2001). Pax6 is required for the multipotent state of retinal progenitor
cells. Cell 105, 43–55. doi: 10.1016/S0092-8674(01)00295-1
Marshall, C. A., Novitch, B. G., and Goldman, J. E. (2005). Olig2 directs astro-
cyte and oligodendrocyte formation in postnatal subventricular zone cells.
J. Neurosci. 25, 7289–7298. doi: 10.1523/JNEUROSCI.1924-05.2005
Martin, R. D. (1990). Primate Origins and Evolution. A Phylogenetic Reconstruction.
London: Chapman & Hall.
McBride, D. J., Buckle, A., Van Heyningen, V., and Kleinjan, D. A. (2011). DNaseI
hypersensitivity and ultraconservation reveal novel, interdependent long-range
enhancers at the complex Pax6 cis-regulatory region. PLoS ONE 6:e28616. doi:
10.1371/journal.pone.0028616
McConnell, S. K. (1995). Strategies for the generation of neuronal diversity in the
developing central nervous system. J. Neurosci. 15, 6987–6998.
Mercader, N., Leonardo, E., Azpiazu, N., Serrano, A., Morata, G., Martinez, C.,
et al. (1999). Conserved regulation of proximodistal limb axis development by
Meis1/Hth. Nature 402, 425–429. doi: 10.1038/46580
Mi, D., Carr, C. B., Georgala, P. A., Huang, Y. T., Manuel, M. N., Jeanes, E.,
et al. (2013a). Pax6 exerts regional control of cortical progenitor proliferation
via direct repression of Cdk6 and hypophosphorylation of pRb. Neuron 78,
269–284. doi: 10.1016/j.neuron.2013.02.012S0896-6273(13)00170-0
Mi, D., Huang, Y. T., Kleinjan, D. A., Mason, J. O., and Price, D. J. (2013b).
Identiﬁcation of genomic regions regulating Pax6 expression in embryonic fore-
brain using YAC reporter transgenic mouse lines. PLoS ONE 8:e80208. doi:
10.1371/journal.pone.0080208PONE-D-13-29798
Mikkola, I., Bruun, J. A., Holm, T., and Johansen, T. (2001). Superactivation
of Pax6-mediated transactivation from paired domain-binding sites by dna-
independent recruitment of diﬀerent homeodomain proteins. J. Biol. Chem.
276, 4109–4118. doi: 10.1074/jbc.M008882200
Mitchell, T. N., Free, S. L., Williamson, K. A., Stevens, J. M., Churchill, A. J.,
Hanson, I. M., et al. (2003). Polymicrogyria and absence of pineal gland due
to PAX6 mutation. Ann. Neurol. 53, 658–663. doi: 10.1002/ana.10576
Miyata, T., Kawaguchi, A., Okano, H., and Ogawa, M. (2001). Asymmetric inher-
itance of radial glial ﬁbers by cortical neurons. Neuron 31, 727–741. doi:
10.1016/S0896-6273(01)00420-2
Miyata, T., Kawaguchi, A., Saito, K., Kawano, M., Muto, T., and Ogawa, M. (2004).
Asymmetric production of surface-dividing and non-surface-dividing cortical
progenitor cells. Development 131, 3133–3145. doi: 10.1242/dev.01173
Miyoshi, G., Hjerling-Leﬄer, J., Karayannis, T., Sousa, V. H., Butt, S. J., Battiste,
J., et al. (2010). Genetic fate mapping reveals that the caudal ganglionic emi-
nence produces a large and diverse population of superﬁcial cortical interneu-
rons. J. Neurosci. 30, 1582–1594. doi: 10.1523/JNEUROSCI.4515-09.201030/
5/1582
Mo, Z., and Zecevic, N. (2008). Is Pax6 critical for neurogenesis in the human fetal
brain? Cereb. Cortex 18, 1455–1465. doi: 10.1093/cercor/bhm181
Moens, C. B., and Selleri, L. (2006). Hox cofactors in vertebrate development.Dev.
Biol. 291, 193–206. doi: 10.1016/j.ydbio.2005.10.032
Morgan, R. (2004). Conservation of sequence and function in
the Pax6 regulatory elements. Trends Genet. 20, 283–287. doi:
10.1016/j.tig.2004.04.009S0168952504001076
Moskow, J. J., Bullrich, F., Huebner, K., Daar, I. O., and Buchberg, A. M. (1995).
Meis1, a PBX1-related homeobox gene involved in myeloid leukemia in BXH-2
mice.Mol. Cell Biol. 15, 5434–5443.
Muzio, L., Dibenedetto, B., Stoykova, A., Boncinelli, E., Gruss, P., and Mallamaci,
A. (2002). Emx2 and Pax6 control regionalization of the pre-neuronogenic
cortical primordium. Cereb. Cortex 12, 129–139. doi: 10.1093/cercor/12.2.129
Muzio, L., andMallamaci, A. (2003). Emx1, emx2 and pax6 in speciﬁcation, region-
alization and arealization of the cerebral cortex. Cereb. Cortex 13, 641–647. doi:
10.1093/cercor/13.6.641
Ninkovic, J., Steiner-Mezzadri, A., Jawerka, M., Akinci, U., Masserdotti, G.,
Petricca, S., et al. (2013). The BAF complex interacts with Pax6 in adult
neural progenitors to establish a neurogenic cross-regulatory transcriptional
network. Cell Stem Cell 13, 403–418. doi: 10.1016/j.stem.2013.07.002S1934-
5909(13)00310-X
Noctor, S. C., Flint, A. C., Weissman, T. A., Dammerman, R. S., and Kriegstein,
A. R. (2001). Neurons derived from radial glial cells establish radial units in
neocortex. Nature 409, 714–720. doi: 10.1038/35055553
Noctor, S. C., Martinez-Cerdeno, V., Ivic, L., and Kriegstein, A. R. (2004). Cortical
neurons arise in symmetric and asymmetric division zones andmigrate through
speciﬁc phases. Nat. Neurosci. 7, 136–144. doi: 10.1038/nn1172nn1172
Oikawa, T., and Yamada, T. (2003). Molecular biology of the Ets family of
transcription factors. Gene 303, 11–34. doi: 10.1016/S0378-1119(02)01156-3
O’Leary, D. D., Chou, S. J., and Sahara, S. (2007). Area patterning of the mam-
malian cortex. Neuron 56, 252–269. doi: 10.1016/j.neuron.2007.10.010
Osumi, N., Shinohara, H., Numayama-Tsuruta, K., and Maekawa, M. (2008).
Concise review: Pax6 transcription factor contributes to both embryonic and
adult neurogenesis as a multifunctional regulator. Stem Cells 26, 1663–1672.
doi: 10.1634/stemcells.2007-08842007-0884
Ouyang, J., Shen, Y. C., Yeh, L. K., Li, W., Coyle, B. M., Liu, C. Y., et al. (2006).
Pax6 overexpression suppresses cell proliferation and retards the cell cycle
in corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 47, 2397–2407. doi:
10.1167/iovs.05-1083
Paige, S. L., Thomas, S., Stoick-Cooper, C. L., Wang, H., Maves, L., Sandstrom,
R., et al. (2012). A temporal chromatin signature in human embryonic stem
cells identiﬁes regulators of cardiac development. Cell 151, 221–232. doi:
10.1016/j.cell.2012.08.027S0092-8674(12)01058
Petanjek, Z., Dujmovic, A., Kostovic, I., and Esclapez, M. (2008). Distinct origin
of GABA-ergic neurons in forebrain of man, nonhuman primates and lower
mammals. Coll. Antropol. 32(Suppl. 1), 9–17.
Philips, G. T., Stair, C. N., Young Lee, H., Wroblewski, E., Berberoglu, M. A.,
Brown, N. L., et al. (2005). Precocious retinal neurons: Pax6 controls timing
of diﬀerentiation and determination of cell type. Dev. Biol. 279, 308–321. doi:
10.1016/j.ydbio.2004.12.018
Pinson, J., Simpson, T. I., Mason, J. O., and Price, D. J. (2006). Positive autoregula-
tion of the transcription factor Pax6 in response to increased levels of either of
its major isoforms, Pax6 or Pax6(5a), in cultured cells. BMC Dev. Biol. 6:25. doi:
10.1186/1471-213X-6-25
Plaza, S., Aumercier, M., Bailly, M., Dozier, C., and Saule, S. (1999a). Involvement
of poly (ADP-ribose)-polymerase in the Pax-6 gene regulation in neuroretina.
Oncogene 18, 1041–1051. doi: 10.1038/sj.onc.1202406
Plaza, S., Saule, S., and Dozier, C. (1999b). High conservation of cis-regulatory
elements between quail and human for the Pax-6 gene. Dev. Genes Evol. 209,
165–173. doi: 10.1007/s004270050240
Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koﬀ, A., Roberts, J. M., Tempst,
P., et al. (1994). Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and
a potential mediator of extracellular antimitogenic signals. Cell 78, 59–66. doi:
10.1016/0092-8674(94)90572-X
Price, D. J., Aslam, S., Tasker, L., and Gillies, K. (1997). Fates of the earliest gener-
ated cells in the developing murine neocortex. J. Comp. Neurol. 377, 414–422.
doi: 10.1002/(SICI)1096-9861(19970120)377:3<414::AID-CNE8>3.0.CO;2-5
Puschel, A. W., Gruss, P., and Westerﬁeld, M. (1992). Sequence and expression
pattern of pax-6 are highly conserved between zebraﬁsh and mice.Development
114, 643–651.
Quinn, J. C., Molinek,M., Martynoga, B. S., Zaki, P. A., Faedo, A., Bulfone, A., et al.
(2007). Pax6 controls cerebral cortical cell number by regulating exit from the
Frontiers in Cellular Neuroscience | www.frontiersin.org 19 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
cell cycle and speciﬁes cortical cell identity by a cell autonomous mechanism.
Dev. Biol. 302, 50–65. doi: 10.1016/j.ydbio.2006.08.035
Rakic, P. (1974). Neurons in rhesus monkey visual cortex: systematic relation
between time of origin and eventual disposition. Science 183, 425–427. doi:
10.1126/science.183.4123.425
Rakic, P. (1988). Speciﬁcation of cerebral cortical areas. Science 241, 170–176. doi:
10.1126/science.3291116
Richardson, J., Cvekl, A., and Wistow, G. (1995). Pax-6 is essential for lens-speciﬁc
expression of zeta-crystallin. Proc. Natl. Acad. Sci. U.S.A. 92, 4676–4680. doi:
10.1073/pnas.92.10.4676
Salomoni, P., and Calegari, F. (2010). Cell cycle control of mammalian neural
stem cells: putting a speed limit on G1. Trends Cell Biol. 20, 233–243. doi:
10.1016/j.tcb.2010.01.006
Sansom, S. N., Griﬃths, D. S., Faedo, A., Kleinjan, D. J., Ruan, Y., Smith, J., et al.
(2009). The level of the transcription factor Pax6 is essential for controlling the
balance between neural stem cell self-renewal and neurogenesis. PLoS Genet.
5:e1000511. doi: 10.1371/journal.pgen.1000511
Sansom, S. N., and Livesey, F. J. (2009). Gradients in the brain: the control of the
development of form and function in the cerebral cortex. Cold Spring Harb.
Perspect. Biol. 1, a002519. doi: 10.1101/cshperspect.a002519
Scardigli, R., Baumer, N., Gruss, P., Guillemot, F., and Le Roux, I. (2003). Direct
and concentration-dependent regulation of the proneural gene Neurogenin2
by Pax6. Development 130, 3269–3281. doi: 10.1242/dev.00539
Schedl, A., Ross, A., Lee, M., Engelkamp, D., Rashbass, P., Van Heyningen, V.,
et al. (1996). Inﬂuence of PAX6 gene dosage on development: overexpression
causes severe eye abnormalities. Cell 86, 71–82. doi: 10.1016/S0092-8674(00)
80078-1
Schmahl, W., Knoedlseder, M., Favor, J., and Davidson, D. (1993). Defects of neu-
ronal migration and the pathogenesis of cortical malformations are associated
with Small eye (Sey) in the mouse, a point mutation at the Pax-6-locus. Acta
Neuropathol. (Berl.) 86, 126–135. doi: 10.1007/BF00334879
Schmidt-Sidor, B., Szymanska, K.,Williamson,K., VanHeyningen, V., Roszkowski,
T., Wierzba-Bobrowicz, T., et al. (2009). Malformations of the brain in two
fetuses with a compound heterozygosity for two PAX6 mutations. Folia
Neuropathol. 47, 372–382.
Schuurmans, C., Armant, O., Nieto, M., Stenman, J. M., Britz, O., Klenin, N.,
et al. (2004). Sequential phases of cortical speciﬁcation involve Neurogenin-
dependent and -independent pathways. EMBO J. 23, 2892–2902. doi:
10.1038/sj.emboj.7600278
Sheng, G., Thouvenot, E., Schmucker, D., Wilson, D. S., and Desplan, C. (1997).
Direct regulation of rhodopsin 1 by Pax-6/eyeless in Drosophila: evidence
for a conserved function in photoreceptors. Genes Dev. 11, 1122–1131. doi:
10.1101/gad.11.9.1122
Sherr, C. J., and Roberts, J. M. (1995). Inhibitors of mammalian G1 cyclin-
dependent kinases. Genes Dev. 9, 1149–1163. doi: 10.1101/gad.9.10.1149
Shimizu, N., Watanabe, H., Kubota, J., Wu, J., Saito, R., Yokoi, T., et al. (2009).
Pax6-5a promotes neuronal diﬀerentiation of murine embryonic stem cells.
Biol. Pharm. Bull. 32, 999–1003. doi: 10.1248/bpb.32.999
Shimoda, Y., Tajima, Y., Osanai, T., Katsume, A., Kohara, M., Kudo, T., et al.
(2002). Pax6 controls the expression of Lewis x epitope in the embryonic fore-
brain by regulating alpha 1,3-fucosyltransferase IX expression. J. Biol. Chem.
277, 2033–2039. doi: 10.1074/jbc.M108495200
Singh, S., Chao, L. Y., Mishra, R., Davies, J., and Saunders, G. F. (2001). Missense
mutation at the C-terminus of PAX6 negatively modulates homeodomain
function. Hum. Mol. Genet. 10, 911–918. doi: 10.1093/hmg/10.9.911
Singh, S., Stellrecht, C. M., Tang, H. K., and Saunders, G. F. (2000). Modulation
of PAX6 homeodomain function by the paired domain. J. Biol. Chem. 275,
17306–17313. doi: 10.1074/jbc.M000359200
Singh, S., Tang, H. K., Lee, J. Y., and Saunders, G. F. (1998). Truncation mutations
in the transactivation region of PAX6 result in dominant-negative mutants.
J. Biol. Chem. 273, 21531–21541. doi: 10.1074/jbc.273.34.21531
Singhal, N., Graumann, J., Wu, G., Arauzo-Bravo, M. J., Han, D. W., Greber, B.,
et al. (2010). Chromatin-remodeling components of the BAF complex facili-
tate reprogramming. Cell 141, 943–955. doi: 10.1016/j.cell.2010.04.037S0092-
8674(10)00491-5
Sisodiya, S. M., Free, S. L., Williamson, K. A., Mitchell, T. N., Willis, C., Stevens,
J. M., et al. (2001). PAX6 haploinsuﬃciency causes cerebral malformation and
olfactory dysfunction in humans. Nat. Genet. 28, 214–216. doi: 10.1038/90042
Skogh, C., Eriksson, C., Kokaia, M., Meijer, X. C., Wahlberg, L. U., Wictorin, K.,
et al. (2001). Generation of regionally speciﬁed neurons in expanded glial cul-
tures derived from themouse and human lateral ganglionic eminence.Mol. Cell.
Neurosci. 17, 811–820. doi: 10.1006/mcne.2001.0973S1044-7431(01)90973-X
Smart, I. H., Dehay, C., Giroud, P., Berland, M., and Kennedy, H. (2002). Unique
morphological features of the proliferative zones and postmitotic compart-
ments of the neural epithelium giving rise to striate and extrastriate cortex in
the monkey. Cereb. Cortex 12, 37–53. doi: 10.1093/cercor/12.1.37
Solomon, B. D., Pineda-Alvarez, D. E., Balog, J. Z., Hadley, D., Gropman,
A. L., Nandagopal, R., et al. (2009). Compound heterozygosity for muta-
tions in PAX6 in a patient with complex brain anomaly, neonatal diabetes
mellitus, and microophthalmia. Am. J. Med. Genet. A 149A, 2543–2546. doi:
10.1002/ajmg.a.33081
Stenman, J., Yu, R. T., Evans, R. M., and Campbell, K. (2003a). Tlx and Pax6 co-
operate genetically to establish the pallio-subpallial boundary in the embryonic
mouse telencephalon. Development 130, 1113–1122. doi: 10.1242/dev.00328
Stenman, J. M., Wang, B., and Campbell, K. (2003b). Tlx controls proliferation
and patterning of lateral telencephalic progenitor domains. J. Neurosci. 23,
10568–10576.
Stiles, J., and Jernigan, T. L. (2010). The basics of brain development.Neuropsychol.
Rev. 20, 327–348. doi: 10.1007/s11065-010-9148-4
Stoykova, A., and Gruss, P. (1994). Roles of Pax-genes in developing and adult
brain as suggested by expression patterns. J. Neurosci. 14, 1395–1412.
Stoykova, A., Treichel, D., Hallonet, M., and Gruss, P. (2000). Pax6 modulates
the dorsoventral patterning of the mammalian telencephalon. J. Neurosci. 20,
8042–8050.
Takahashi, T., Nowakowski, R. S., and Caviness, V. S. Jr. (1993). Cell cycle param-
eters and patterns of nuclear movement in the neocortical proliferative zone of
the fetal mouse. J. Neurosci. 13, 820–833.
Takahashi, T., Nowakowski, R. S., and Caviness, V. S. Jr. (1995). The cell cycle of
the pseudostratiﬁed ventricular epithelium of the embryonic murine cerebral
wall. J. Neurosci. 15, 6046–6057.
Tan, X., and Shi, S. H. (2013). Neocortical neurogenesis and neuronal migration.
Wiley Interdiscip. Rev. Dev. Biol. 2, 443–459. doi: 10.1002/wdev.88
Tang, H. K., Singh, S., and Saunders, G. F. (1998). Dissection of the transactiva-
tion function of the transcription factor encoded by the eye developmental gene
PAX6. J. Biol. Chem. 273, 7210–7221. doi: 10.1074/jbc.273.13.7210
Tarabykin, V., Stoykova, A., Usman, N., and Gruss, P. (2001). Cortical upper
layer neurons derive from the subventricular zone as indicated by Svet1 gene
expression. Development 128, 1983–1993.
Tominaga, T., Meng, W., Togashi, K., Urano, H., Alberts, A. S., and Tominaga,
M. (2002). The Rho GTPase eﬀector protein, mDia, inhibits the DNA binding
ability of the transcription factor Pax6 and changes the pattern of neurite exten-
sion in cerebellar granule cells through its binding to Pax6. J. Biol. Chem. 277,
47686–47691. doi: 10.1074/jbc.M207539200M207539200
Ton, C. C., Miwa, H., and Saunders, G. F. (1992). Small eye (Sey): cloning and char-
acterization of the murine homolog of the human aniridia gene. Genomics 13,
251–256. doi: 10.1016/0888-7543(92)90239-O
Toresson, H., Potter, S. S., and Campbell, K. (2000). Genetic control of dorsal-
ventral identity in the telencephalon: opposing roles for Pax6 and Gsh2.
Development 127, 4361–4371.
Tuoc, T. C., Boretius, S., Sansom, S. N., Pitulescu, M. E., Frahm, J., Livesey, F. J.,
et al. (2013a). Chromatin regulation by BAF170 controls cerebral cortical size
and thickness. Dev. Cell 25, 256–269. doi: 10.1016/j.devcel.2013.04.005S1534-
5807(13)00196-2
Tuoc, T. C., Narayanan, R., and Stoykova, A. (2013b). BAF chromatin remodel-
ing complex: cortical size regulation and beyond. Cell Cycle 12, 2953–2959. doi:
10.4161/cc.2599925999
Tuoc, T. C., Radyushkin, K., Tonchev, A. B., Pinon, M. C., Ashery-Padan, R.,
Molnar, Z., et al. (2009). Selective cortical layering abnormalities and behavioral
deﬁcits in cortex-speciﬁc Pax6 knock-out mice. J. Neurosci. 29, 8335–8349. doi:
10.1523/JNEUROSCI.5669-08.2009
Tuoc, T. C., and Stoykova, A. (2008a). Er81 is a downstream target of Pax6 in
cortical progenitors. BMC Dev. Biol. 8:23. doi: 10.1186/1471-213X-8-231471-
213X-8-23
Tuoc, T. C., and Stoykova, A. (2008b). Trim11 modulates the function of neuro-
genic transcription factor Pax6 through ubiquitin-proteosome system. Genes
Dev. 22, 1972–1986. doi: 10.1101/gad.47170822/14/1972
Frontiers in Cellular Neuroscience | www.frontiersin.org 20 March 2015 | Volume 9 | Article 70
Manuel et al. Pax6 control of cortical neurogenesis
Vidal, A., and Koﬀ, A. (2000). Cell-cycle inhibitors: three families united by a
common cause. Gene 247, 1–15. doi: 10.1016/S0378-1119(00)00092-5
Visel, A., Bristow, J., and Pennacchio, L. A. (2007). Enhancer identiﬁcation
through comparative genomics. Semin. Cell Dev. Biol. 18, 140–152. doi:
10.1016/j.semcdb.2006.12.014
Walcher, T., Xie, Q., Sun, J., Irmler, M., Beckers, J., Ozturk, T., et al. (2013).
Functional dissection of the paired domain of Pax6 reveals molecular mech-
anisms of coordinating neurogenesis and proliferation. Development 140,
1123–1136. doi: 10.1242/dev.082875140/5/1123
Wang, B., Long, J. E., Flandin, P., Pla, R., Waclaw, R. R., Campbell, K., et al. (2013).
Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants.
J. Comp. Neurol. 521, 1561–1584. doi: 10.1002/cne.23242
Warren, N., Caric, D., Pratt, T., Clausen, J. A., Asavaritikrai, P., Mason, J. O., et al.
(1999). The transcription factor, Pax6, is required for cell proliferation and dif-
ferentiation in the developing cerebral cortex. Cereb. Cortex 9, 627–635. doi:
10.1093/cercor/9.6.627
Westerman, B. A., Murre, C., and Oudejans, C. B. (2003). The cellu-
lar Pax-Hox-helix connection. Biochim. Biophys. Acta 1629, 1–7. doi:
10.1016/j.bbaexp.2003.08.002
Williams, S. C., Altmann, C. R., Chow, R. L., Hemmati-Brivanlou, A., and
Lang, R. A. (1998). A highly conserved lens transcriptional control element
from the Pax-6 gene. Mech. Dev. 73, 225–229. doi: 10.1016/S0925-4773(98)0
0057-4
Wilson, D., Sheng, G., Lecuit, T., Dostatni, N., and Desplan, C. (1993). Cooperative
dimerization of paired class homeo domains on DNA.Genes Dev. 7, 2120–2134.
doi: 10.1101/gad.7.11.2120
Wolf, L. V., Yang, Y., Wang, J., Xie, Q., Braunger, B., Tamm, E. R., et al. (2009).
Identiﬁcation of pax6-dependent gene regulatory networks in the mouse lens.
PLoS ONE 4:e4159. doi: 10.1371/journal.pone.0004159
Wonders, C. P., and Anderson, S. A. (2006). The origin and speciﬁcation of cortical
interneurons. Nat. Rev. Neurosci. 7, 687–696. doi: 10.1038/nrn1954
Wu, J. I. (2012). Diverse functions of ATP-dependent chromatin remodeling com-
plexes in development and cancer. Acta Biochim. Biophys. Sin. (Shanghai) 44,
54–69. doi: 10.1093/abbs/gmr099gmr099
Xie, Q., and Cvekl, A. (2011). The orchestration of mammalian tissue morpho-
genesis through a series of coherent feed-forward loops. J. Biol. Chem. 286,
43259–43271. doi: 10.1074/jbc.M111.264580
Xie, Q., Yang, Y., Huang, J., Ninkovic, J., Walcher, T., Wolf, L., et al. (2013). Pax6
interactions with chromatin and identiﬁcation of its novel direct target genes in
lens and forebrain. PLoS ONE 8:e54507. doi: 10.1371/journal.pone.0054507
Xu, H. E., Rould, M. A., Xu, W., Epstein, J. A., Maas, R. L., and Pabo, C. O.
(1999a). Crystal structure of the human Pax6 paired domain-DNA complex
reveals speciﬁc roles for the linker region and carboxy-terminal subdomain in
DNA binding. Genes Dev. 13, 1263–1275. doi: 10.1101/gad.13.10.1263
Xu, P. X., Zhang, X., Heaney, S., Yoon, A., Michelson, A. M., and Maas, R. L.
(1999b). Regulation of Pax6 expression is conserved between mice and ﬂies.
Development 126, 383–395.
Yan, Z., Wang, Z., Sharova, L., Sharov, A. A., Ling, C., Piao, Y., et al. (2008).
BAF250B-associated SWI/SNF chromatin-remodeling complex is required to
maintain undiﬀerentiated mouse embryonic stem cells. Stem Cells 26, 1155–
1165. doi: 10.1634/stemcells.2007-08462007-0846
Yip, D. J., Corcoran, C. P., Alvarez-Saavedra, M., Demaria, A., Rennick,
S., Mears, A. J., et al. (2012). Snf2l regulates Foxg1-dependent progeni-
tor cell expansion in the developing brain. Dev. Cell 22, 871–878. doi:
10.1016/j.devcel.2012.01.020S1534-5807(12)00054-8
Yoneshima, H., Yamasaki, S., Voelker, C. C., Molnar, Z., Christophe, E., Audinat,
E., et al. (2006). Er81 is expressed in a subpopulation of layer 5 neu-
rons in rodent and primate neocortices. Neuroscience 137, 401–412. doi:
10.1016/j.neuroscience.2005.08.075
Yun, K., Potter, S., and Rubenstein, J. L. (2001). Gsh2 and Pax6 play complementary
roles in dorsoventral patterning of the mammalian telencephalon.Development
128, 193–205.
Zaki, P. A., Quinn, J. C., and Price, D. J. (2003). Mouse models of telen-
cephalic development.Curr. Opin. Genet. Dev. 13, 423–437. doi: 10.1016/S0959-
437X(03)00084-4
Zecevic, N., Chen, Y., and Filipovic, R. (2005). Contributions of cortical subven-
tricular zone to the development of the human cerebral cortex. J. Comp. Neurol.
491, 109–122. doi: 10.1002/cne.20714
Zetterberg, A., Larsson, O., and Wiman, K. G. (1995). What is the restric-
tion point? Curr. Opin. Cell Biol. 7, 835–842. doi: 10.1016/0955-0674(95)
80067-0
Zhang, W., Cveklovam, K., Oppermann, B., Kantorow, M., and Cvekl, A. (2001).
Quantitation of PAX6 and PAX6(5a) transcript levels in adult human lens,
cornea, and monkey retina.Mol. Vis. 7, 1–5.
Zhou, Y. H., Wu, X., Tan, F., Shi, Y. X., Glass, T., Liu, T. J., et al. (2005). PAX6 sup-
presses growth of human glioblastoma cells. J. Neurooncol. 71, 223–229. doi:
10.1007/s11060-004-1720-4
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or ﬁnancial relationships that could be
construed as a potential conﬂict of interest.
Copyright © 2015 Manuel, Mi, Mason and Price. This is an open-access article dis-
tributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Cellular Neuroscience | www.frontiersin.org 21 March 2015 | Volume 9 | Article 70
